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ABSTRACT

Author: Hudson, Joshua, L. PhD
Institution: Purdue University
Degree Received: May 2018
Title: Effects of Within-Day Dietary Protein Distribution on Changes in Plasma Amino Acid
Concentrations and Body Composition
Committee Chair: Wayne W. Campbell, PhD
The increasing prevalence of adults with overweight and obesity in the United States
emphasizes the need for research on novel behavioral and lifestyle interventions such as dietary
manipulation to modulate the epidemic. While consuming an energy-restricted diet is a proven
method of reducing adiposity, adhering to and adopting a diet that is not self-chosen is difficult.
Not unimportantly, reducing energy intake also typically results in a reduction in skeletal muscle
mass. Skeletal muscle is important for facilitating functional movements, metabolizing glucose,
and contributing to resting energy expenditure. Multitudinous research has focused on the
macronutrient composition of an energy-restricted diet both to improve adherence and reduce
skeletal muscle loss. Previous research showed that consuming a higher protein diet (1.2-1.5
g/kg/d) may attenuate the loss of skeletal muscle mass vs a lower-protein diet with similar
reductions in body weight.
Adults in the United States and in most developed countries typically consume very little
protein at breakfast, slightly more at lunch, and the majority at dinner. This skewed distribution
pattern limits the meals available for increasing protein quantity. While the exact within-day
protein distributions from the studies assessing the effect of consuming a higher-protein diet vs a
lower-protein diet on skeletal muscle changes are unknown, it is feasible that the protein contents
of breakfast and lunch were increased, in part, due to the practical limitations of adding more
protein to dinner. In effect, consuming a higher protein diet may results in a more even protein
distribution pattern. Evenly distributing protein throughout the day could feasibly upregulate
muscle protein synthesis more frequently, attenuating skeletal muscle loss.
Study 1 (Chapter 2) of this document was designed to assess the effects of within-day
protein intake distribution on changes in body composition during dietary energy restriction and
resistance training. We hypothesized that consuming an even protein distribution would result in
greater lean mass retention. Contrary to our hypothesis, the effectiveness of dietary energy
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restriction combined with resistance training to improve body composition is not influenced by
the within-day distribution of protein when adequate total protein is consumed.
Consuming an even protein distribution inevitably results in higher protein-containing
breakfasts and lunches. Breakfast is traditionally characterized as being carbohydrate-rich and
altering habitual breakfast habits can be particularly challenging, in part, due to practical
limitations such as convenience, appetite, and cultural influence. One method to increase the
protein quantity of breakfast may be to leverage the rapid digestion and absorption kinetics of
whey protein. Amino acids from meals peak in the plasma at ~180 minutes postprandial.
Conversely, amino acids from rapidly digestible whey protein appear in the plasma within 15
minutes and peak at 60 minutes postprandial. In study 2 (Chapter 3), we hypothesized that
consuming a 20-g whey protein snack 2 hours after a standard mixed-macronutrient, lower protein
breakfast (10 g) would result in peak and composite postprandial plasma essential amino acid
(EAA) responses that were not different from consuming a 30-g protein breakfast alone. We found
that consuming a rapidly digested whey protein snack 2 hours after a slowly digested, lower protein
breakfast resulted in a greater peak plasma EAA concentration but comparable plasma EAA
availability than consuming a single higher protein breakfast
Consuming a protein supplement 120 minutes after breakfast may also impact body weight
by manipulating ingestive behaviors. Limited observational and clinical trial evidence suggests
that consuming energy-containing beverages between meals effectively increases daily meal
frequency and contributes to higher body weights. If true, it’s possible that the timing of protein
supplementation ingestion relative to meal times would impact changes in body weight in adults
consuming a “self-chosen” diet. In study 3 (Chapter 4) we conducted a systematic review of
literature to investigate whether the existing research studies support consuming protein
supplements between meals versus with meals to differentially change body composition in adults
who initiate resistance training regimens. Regardless of protein supplement timing in relation to
meals, lean mass is likely to increase in response to resistance training. However, consuming
protein supplements with meals rather than between meals may be a more effective dietary strategy
to improve resistance training-induced changes in body composition by reducing fat mass, which
may be relevant for adults undergoing purposeful weight loss to improve their health status.
Conversely, consuming protein supplements between meals may be more effective at increasing
overall body mass.

1

CHAPTER 1. LITERATURE REVIEW

1.1

Adults with overweight and obesity in the United States
Over two-thirds of the current population is classified as having an overweight (25.0-29.9

kg/m2) or obese BMI (>30.0 kg/m2) (1, 2). Over the past four decades the prevalence of overweight
has remained relatively stable while the obesity (BMI ≥ 30 kg/m2) prevalence doubled (3). It’s
presumed that adults with a normal BMI (BMI: 18.5-24.9 kg/m2) moved up to replace the
individuals moving from an overweight to an obese BMI. Research supports this, showing that
adults with a greater BMI are more likely to gain weight over time (4-6). It logically follows that
there would be a growing number of individuals who are class III obese (BMI ≥ 40 kg/m 2). Data
from the Behavioral Risk Factor Surveillance System showed that the prevalence of class III
obesity increased by 70% between 2000 and 2010 (7). Nearly 15.5 million Americans or 6.6% of
the population were estimated to be class III obese in 2010 after adjusting for self-reporting bias
(7). Higher BMIs are associated with deleterious financial and medical consequences coming from
the development of obesity-related diseases. Obesity-related medical expenditures were estimated
at $147 billion in 2008, with obese adults spending ~42% more on healthcare-related expenses
than normal weight individuals (8). Higher healthcare costs may be attributable to the treatment
expenses that come with the development of chronic morbidities such as cardiovascular disease
(CVD), type II diabetes (T2D), respiratory diseases, metabolic syndrome, and certain types of
cancers (9). These data highlight the importance of targeting nutritional and behavioral
interventions to alleviate the substantial medical and financial encumbrances attributable to obesity.

1.2

Health concerns associated with excess adiposity

1.2.1 Relationship between obesity and metabolic syndrome
The body mass index provides a useful operational definition for determining an
individual’s relative adiposity and weight status. A higher BMI is generally associated with greater
chronic disease risk. Clustering metabolic abnormalities such as hyperglycemia, hypertension, and
hyperlipidemia in conjunction with BMI may provide a more comprehensive assessment of an
individual’s risk for developing chronic morbidities such as type II diabetes or cardiovascular
disease. This “cluster” of conditions is known as metabolic syndrome, and together they increase
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a person’s risk for developing serious diseases. The National Heart, Lung, and Blood Institute
diagnoses metabolic syndrome as having at least three of the five following metabolic risk factors:
a large waist circumference (≥ 35 in for women, ≥ 40 in for men), a high triglyceride concentration
(≥ 150 mg/dL or on medicine to treat hypertriglyceridemia), a low high-density lipo-protein
cholesterol concentration (< 50 mg/dL for women, < 40 mg/dL for men), high blood pressure ( ≥
130/85 mm Hg or on medicine to treat high blood pressure), and high fasting blood sugar (≥ 100
mg/dL or on medicine to treat hyperglycemia). According to results from the 1999-2004 NHANES,
the age-adjusted metabolic syndrome prevalence was 36.3% for adults age 20 y and older (10),
which closely mirrors the obesity prevalence. Results from the Dallas Heart Study, showed that
BMI was associated with metabolic syndrome in patients with and without diabetes (11). However,
this may not be surprising given that waist circumference, which is associated with obesity, is a
risk factor for metabolic syndrome. These data highlight the need for targeted lifestyle
interventions such as weight loss to reduce the obesity prevalence and the risk for developing
metabolic syndrome.
The association between weight loss and improvement in health outcomes were reinforced
by results from the Finnish Diabetes Prevention Study showing that intentional weight loss alone
and when combined with other lifestyle interventions were associated with reductions in metabolic
syndrome diagnoses (odds ratio = 0.62; 95%CI = 0.40-0.95) (12). A 12-month RCT (RCT) of 180
women and 44 men between 18 and 65 y (BMI: 30-45 kg/m2) found similar results (13). The
prevalence of metabolic syndrome decreased from 35% to 27% when subjects lost 8 kg of body
mass. Weight loss and the subsequent improvements in metabolic syndrome risk factors may also
decrease the risk for developing chronic morbidities such as T2D.
1.2.2 Obesity and cardiovascular disease risk
Obesity alone is considered a major modifiable risk factor for developing CVD and
evidence from prospective and observational studies support the deleterious effect of obesity on
CVD development (14-22). Cardiovascular disease is a broad definition that includes coronary
heart disease, myocardial infarction, angina pectoris, congestive heart failure, stroke, hypertension,
and atrial fibrillation (23). The Multiethnic Study of Atherosclerosis (an observational cohort study
including 6,814 subjects aged 45-84 y) showed that hypertension was more prevalent in obese
subjects than non-obese subjects (15). The International Day for the Evaluation of Abdominal
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Obesity Study (IDEA) evaluated over 168,000 primary care patients for risk factors of CVD across
63 countries and reported that the risk for developing CVD was associated with obesity (16).
Results from the original cohort of the Framingham Heart Study (5,209 participants) showed that
having a BMI ≥ 30.0 kg/m2 increased the age-adjusted relative risk of developing CVD by 146%
in men and 164% in women compared to those with a normal BMI (14). Among 7,000 British men
followed for 20 y, the age-adjusted relative risk for having a major CVD event was 1.78 for those
with a BMI ≥ 30.0 kg/m2 compared to those with a BMI < 25.0 kg/m2 (17). When individuals
gained > 10% of their body weight over the 15 y follow-up period, the relative risk for having a
major CVD event was 1.32 compared to individuals who were weight stable (17).
Weight loss has shown to be effective at reducing CVD risk factors such as high blood
pressure and hyperlipidemia (24-27), but the effect of weight loss on reducing the risk for
developing CVD is less well documented. For example, one prospective cohort study showed that
after 15 y, the relative risk for men with a BMI 27.5-29.9 kg/m2 having a major CVD event after
losing weight was 0.78 (95%CI: 0.56-1.08) compared to individuals who were weight stable;
however, individuals with a BMI ≥ 30 kg/m2 had a relative risk of 1.25 (95%CI: 0.83-1.86) after
losing weight (17). Similarly, the Look AHEAD study was designed to assess the effect of weight
loss on CVD risk in over 5,000 overweight and obese patients with T2D (28). After a median
follow-up of 9.6 y, the trial was stopped prematurely because the incidence of CVD events were
not different between the control and intervention groups (control: 418/1,000; intervention:
403/1,000; CVD incidences/1,000 subjects). However, the authors concluded that perhaps greater
weight loss is needed than what was achieved in the intervention group or that the use of statins in
the control group lessened the difference between the two groups. In support of this, a 12-y
prospective analysis of nearly 5,000 overweight individuals with T2D aged 40-64 y between 1959
and 1972 found that intentional weight loss was associated with a 28% reduction in CVD related
mortality rates (29). These results were mirrored in the Swedish Obese Subjects study (nonrandomized, prospective, controlled study) that assessed the effect of weight loss in over 2,000
individuals after bariatric surgery across 25 public surgical departments (30, 31). Results from this
study showed that after bariatric surgery and subsequent weight loss, the number of CVD related
events decreased compared to the control group. Collectively, these data support the role of
intentional weight loss for individuals with obesity to reduce their risk for CVD related events and
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mortality. However, the feasibility of adopting an energy-restricted diet long-term to achieve
weight loss should be considered.

1.3

Available obesity treatment options
Adults attempting to undergo intentional weight loss have a myriad of options available to

them. Although the full list of available weight loss approaches is beyond the scope of this review,
the following will group them into pharmacological, surgical, and behavioral categories for the
sake of comparing their strengths, limitations, and risks. When addressing each of the categories,
it’s important to consider that they can be achieved through multiple approaches (pharmacological:
types of weight-loss drugs; surgical: sleeve gastrectomy, roux-en-Y, gastric banding; behavioral:
dietary energy restriction, exercise-induced energy restriction, cognitive behavioral therapy), and
used in conjunction with one another (e.g. energy restriction and sleeve gastrectomy). The
following will broadly attempt to characterize each approach using results from meta-analyses and
systematic reviews when appropriate.
1.3.1 Pharmacological treatment options
According to the Endocrine Society (co-sponsored by European Society of Endocrinology
and The Obesity Society), pharmacotherapy should be used in conjunction with behavior therapy
and bariatric surgery to reduce energy intake and promote weight loss when an individual’s BMI
is ≥ 30.0 kg/m2 (32). Even for normal and overweight individuals, diet and exercise are promoted
for healthy weight management. As a result, pharmacologic trials often include behavioral
modifications to both the intervention and control groups. Results from these studies should be
interpreted by considering the additive effects of pharmacotherapy with behavioral modifications
on weight loss rather than the pharmacological effects alone (32).
As of December, 2014, there were 7 pharmacological weight-loss drugs approved by the
Food and Drug Administration. Their precise mechanisms of action are outside the scope of this
review. Orlistat is one drug that works by reducing fat absorption in the small intestine, effectively
reducing energy intake and promoting a negative energy balance. The remaining drugs work on
targeting appetitive mechanisms by reducing the subjective feelings of hunger that are often
experienced when following a weight loss program (33). Orlistat (pancreatic and gastric lipase
inhibitor) was approved in 1999 for chronic weight management in two doses, over-the-counter
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(60 mg) and prescription (120 mg). Taking orlistat, regardless of dose, in conjunction with dietary
and lifestyle modifications typically results in 2.9 kg to 3.4 kg of greater weight loss than the
control. Phentermine resin and Diethylpropion (norepinephrine-releasing agents) were approved
in the 1960s for periods ≤ 3 months and were shown to increase weight loss by 3.6 kg and 3.0 kg
above the control groups, respectively (32). Both Lorcaserin (5HT2c receptor agonist) and
phentermine (GABA receptor modulation plus norepinephrine-releasing agent) were approved in
2012 for long-term use, but phentermine use resulted in greater weight loss compared to the control
(phentermine: 6.6 kg; lorcaserin: 3.6 kg; greater weight loss compared to control). In 2014,
Naltrexon/buproprione (reuptake inhibitor of dopamine and norepinephrine and opioid antagonist)
and liraglutide (injectable glucagon-like peptide-1 agonist) were approved for chronic weight
management use, citing 4.8% or 5.8 kg of greater weight loss in the intervention group than the
control group, respectively.
Although these drugs offer a convenient method to increase weight loss over time, many
come with drawbacks or risks that may be undesirable (32). Phentermine resin and diethylpropion
use can commonly result in minor side effects such as headaches, elevated blood pressure,
insomnia, dry mouth, and anxiety. Taking orlistat can result in decreased absorption of fat soluble
vitamins, steatorrhea, fecal urgency, and fecal incontinence. Taking lorcaserin, phentermine,
naltrexone/bupropion, and liraglutide, often results in headaches, nausea, and vomiting.
Furthermore, it is widely accepted that weight gain may rapidly occur if drug use is discontinued.
Adjunctive behavioral and pharmacological approaches are recommended for sustained weight
management.
1.3.2 Surgical treatment options
According to the National Institute of Diabetes and Digestive and Kidney Diseases,
bariatric surgery may be an option for weight loss for adults who have a BMI ≥ 40 kg/m 2 or have
a BMI ≥ 35 kg/m2 in conjunction with a serious comorbidity such as T2D, CVD, or sleep apnea.
Adults with a BMI ≥ 30 kg/m2 that also have comorbidities are also eligible for bariatric surgery
but are limited to the gastric banding procedure only. Generally, bariatric surgery induces weight
loss by modifying the digestive system to reduce energy intake (34, 35). However, different
bariatric methods approach this from modifying either the stomach or the intestine. Currently, the
most prevalent bariatric surgeries are the sleeve gastrectomy and gastric bypass. A sleeve
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gastrectomy involves removing part of the stomach to reduce the amount of food that can be
consumed at one sitting (35). Gastric bypass, or Roux-en-Y gastric bypass, involves reducing the
size of the stomach to create a 15-30 mL pouch. However, part of the upper small intestine is
removed and reattached to the pouch to also reduce nutrient absorption (35). Another approach is
the laparoscopic adjustable gastric band, which is placed around the top of the stomach, below the
gastroesophageal junction, to form a 30 mL pouch, creating a premature “full effect” which
terminates eating (35).
Perhaps not surprisingly, the prevalence of all bariatric procedures has risen dramatically
over the past few decades (35), mirroring the increase in obesity. Between 1998 and 2004 alone,
bariatric surgeries increased by over 800% (36). Regardless of the method used, bariatric surgery
is more effective at sustaining weight loss than non-surgical treatments such behavioral
modifications or pharmacotherapy (37, 38). In a recent meta-analysis of ~800 individuals with a
BMI ≥ 30 kg/m2, bariatric surgery resulted in 26 kg of greater weight loss than non-surgical
procedures (39). Behavioral and pharmacological treatments often result in short-term weight loss
of 5% to 10% of body weight; however, these approaches do not demonstrate long-term success
for weight management (40-42). Conversely, individuals undergoing bariatric surgery often report
losing 50-75% of excess body weight (43, 44) and maintain their new weight longer than following
non-surgical treatments (45, 46). Adults with bariatric surgery also have improved remission rates
of T2D, metabolic syndrome, and dyslipidemia compared to non-surgical treatments, which may
be mediated through improvement in weight loss (39).
Despite the advantages of bariatric surgery to achieve weight loss, the various procedures
often present complications in the form of abdominal pain, diarrhea, gastrointestinal bleeding,
wound infections, and suboptimal weight loss (47). Abdominal pain is the most common side
effect of gastric bypass, but also the most varied. Abdominal pain may occur due to leaks, strictures,
and ulcers at an anastomosis; or due to bowel mobilization including strictures, adhesion, and
internal hernias. There are many more complications that can follow bariatric surgery and for a
more in-depth analysis the reader is directed to a review on the topic (48).
1.3.3 Behavioral treatment options
According to the National, Heart, Lung, and Blood Institute, behavioral treatment should
be the first approach for attempting weight loss (49). Generally, behavioral treatments include
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intentional weight loss using either dietary energy restriction, exercise, cognitive behavioral
therapy, or a combination of the three. Previously described, the Look AHEAD study was a RCT
designed to assess the effect of intensive lifestyle interventions (diet-induced energy restriction
combined with exercise) versus an enhanced usual care condition on over 5,000 overweight adults
with T2D for up to 12 y (50). The intervention group lost 6.0% of their body weight versus 3.5%
in the control at the end of the study (28). Guidelines from the American Heart Association outline
that weight loss can be achieved through attaining negative energy balance either by energy
restriction or by increasing energy expenditure via exercise (51); however, exercise alone only
incurs modest weight loss (52). When combined, energy restriction and exercise often result in
greater weight loss than either approach independently (53, 54). These effects can be further
compounded by implementing behavioral modifications such as dietary counseling, goal setting,
and self-monitoring in addition to energy restriction and exercise (53, 54).
Significant research efforts have investigated whether the macronutrient composition of a
weight-loss diet can influence the magnitude of body weight lost or the proportion of weight lost
as fat or lean mass. Lean mass preservation during prolonged negative energy balance is of
particular relevance to this review due to the significant contributions of lean mass with regard to
energy expenditure, disease response, glucose metabolism, and functional mobility.

1.4

Significance of lean mass and skeletal muscle in health
Lean mass and skeletal muscle mass are often used interchangeably to reference muscle

quantity. Although lean mass is primarily comprised of skeletal muscle mass, lean mass also
includes organ tissue mass, body water, and trace amounts of fat mass. Whole-body, lean, and fat
mass can be measured using a variety of methods, but dual x-ray absorptiometry and whole body
plethysmography are preferred due to their relatively high precision and reliability compared to
skinfold and bioelectric impedance techniques (55, 56). Magnetic resonance imaging is the gold
standard to fully delineate skeletal muscle from extraneous tissues; however, non-skeletal muscle,
non-fat mass fluctuations are minimal and any changes in lean mass are primarily attributable to
changes in the skeletal muscle (57). Several studies have also reported a good correlation between
lower limb dual x-ray absorptiometry-derived appendicular lean mass and skeletal muscle mass
derived from magnetic resonance imaging (58, 59). Therefore, lean mass and skeletal muscle mass
are used synonymously for the duration of this review.
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1.4.1

Lean mass contributes to resting energy expenditure
Basal energy expenditure is the sum of energy required to maintain healthy cellular

functions such as regulating body temperature and cellular concentration gradients; and to
synthesize and degrade molecules over a 24-h period in a thermo-neutral environment (60).
Resting energy expenditure (REE) is generally about 10% to 20% greater than basal energy
expenditure and is influenced by changes in food intake and activities completed prior to resting
(60). A meta-analysis of seven published studies revealed that lean mass quantity explained up to
73% of the variance in REE (61), indicating that changes in lean mass might influence changes in
REE. With regard to total energy expenditure, the effect of body weight and body size is well
established (61), however, the specific contributions of lean mass are still disputed. It’s generally
accepted that for adults with a normal BMI or with a body fat percentage of 20% to 35%, the
relative amounts of lean or fat mass do not significantly influence total daily energy expenditure.
Adults with obesity have higher total daily energy expenditures than adults with normal BMIs.
This may be because, under most circumstances, REE is the largest component of total energy
expenditure and adults with obesity have greater lean mass than normal weight adults (62-64).
Given the contribution of lean mass to REE, greater lean mass may help adults achieve a negative
energy balance through greater energy expenditures. Attenuating the loss of lean mass during
periods of energy restriction may be important for managing body weight after weight loss via the
same concepts.
1.4.2 Carbohydrate and lipid metabolism in skeletal muscle
Type II diabetes is an insidious disease distinguished by a development of insulin resistance,
a decline in β-cell function, and an inability to metabolize blood glucose (65). The onset of T2D
involves a decrease in blood glucose clearance primarily by the skeletal muscle resulting in
hyperglycemia. Skeletal muscle is the primary tissue responsible for glucose metabolism (66-68)
and the development of insulin resistance decreases the ability of glucose to enter muscle cells.
The pancreas responds by increasing insulin secretion from the β-cells to mobilize tissue glucose
uptake and normalize blood glucose concentrations. Over time, if T2D progresses, it often results
in a complete inability of insulin to mediate tissue glucose uptake. Eventually, the β-cells die and
the pancreas can no longer modulate blood glucose concentrations. Other essential tissues and
organs, such as the brain, can no longer absorb glucose from the blood, but rely on the genesis of
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hepatic ketone bodies for energy. Uncontrolled, this can lead to the development of ketoacidosis
(69).
Excessive adiposity and the development of obesity are associated with the development
of T2D (17, 70). Energy intake beyond energy needs typically results in energy stored in the
adipose tissue as triacylglycerol (TAG). During the post-absorptive period, adults with obesity
convert stored TAGs into free-fatty acids (FFA) have greater blood FFA concentrations compared
to normal weight adults (71). Greater blood FFA concentrations are currently thought to be one
possible cause of ectopic lipid deposition in extraneous tissues such as the liver, brain, and skeletal
muscle (72). Lipid accumulation in skeletal muscle in particular is associated with insulin
resistance (73-76). Intramuscular lipid deposition may not be entirely dependent on FFA
availability but also impaired intramuscular lipid catabolism by declining mitochondrial function
(77). Fatty acids entering the cell are converted to their corresponding fatty-acyl CoAs and are
metabolized in the mitochondria. Mitochondrial dysregulation may increase cytosolic fatty acid
concentrations and promote TAG and phospholipid synthesis. Insulin receptor interference may
be caused by cytosolic diacylglycerol and ceramide accumulation (78). Diacylglycerol and
ceramide are secondary messengers in lipid synthesis pathways that could inhibit insulin signaling
by disrupting the transport of the insulin receptor to the cellular membrane. A disturbance to
skeletal muscle metabolism may therefore be instrumental in the development of T2D. Notably,
other mechanisms for developing insulin resistance have been hypothesized including the Randle
cycle, inflammation state, and mitochondrial stress, however, these topics are outside the scope of
this review. The reader is directed to a review on these topics (72).
1.4.3 Skeletal muscle metabolism in response to acute illness and chronic disease
Adequate protein content in the skeletal muscle and the essential organs (skin, liver, brain,
kidney, heart) is indispensable for sustaining life. In the fasted state, essential organs and tissues
rely on skeletal muscle to supply and maintain adequate plasma amino acid concentrations for
protein synthesis (79-81). Plasma amino acids are also utilized for hepatic gluconeogenesis to
maintain blood glucose concentrations (82). Therefore, skeletal muscle mass determines the
duration that circulating amino acid and glucose concentrations, as well as the protein content of
essential organs, can be maintained during periods void of adequate nutrition. This was
exemplified in one study where obese adults, who have greater skeletal muscle mass, maintained
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normal physiologic plasma amino acid concentrations over a 60 d fast (83). During periods of
adequate nutrition, hepatic amino acid sequestration and gluconeogenesis is reduced allowing
skeletal muscle to replenish intracellular proteins lost during the post-absorptive state (84).
Acute stressors such as sepsis, burns, and surgery increase the amino acid demand
dramatically to synthesize necessary proteins for recovery (e.g. acute phase liver proteins, immune
cells, and wound healing proteins) (85). For example, burn victims with injury to 50% of the body
need > 3 g of protein/kg body weight/day (g/kg/d) compared to 0.8 g/kg/d in a healthy reference
population (86). To provide energy for the protein synthesis reactions, hepatic gluconeogenesis is
upregulated (87). Skeletal muscle breakdown, in turn, upregulates to provide the necessary
precursor amino acids to meet the glucose and amino acid needs of the organs, essential tissues,
or injured area(s) (88). It follows then, that adults with greater skeletal muscle mass (greater protein
content) can provide the necessary amino acids for longer periods than adults with lesser skeletal
muscle mass, which may improve the probability of recovery. An analysis of over 1,600 patients
with severe burns showed that lean mass was associated with greater survival after a 15 y follow
up (89). Survival rate was also reportedly lower in late stage cancer patients who could not
maintain or increase their lean mass over ~5 months (90).
The relation of skeletal muscle and chronic disease is less well documented. Results from
two epidemiological studies showed that reductions in skeletal muscle size are associated with the
development of T2D, certain types of cancers, metabolic syndrome, and CVD (91, 92). The rate
and extent to which skeletal muscle is lost is also associated with survival in adults with CVD or
cancer (93, 94). Without the catabolic effect of disease, aging alone can also result in the loss of
0.5% to 1.0%/y of lean mass after 40 y of age (95). This progressive loss of muscle mass is termed
sarcopenia, which includes dynapenia (muscle strength) (96) and myopenia (muscle mass).
Sarcopenia is a progressive widespread syndrome estimated to affect nearly 200 million adults
globally over the next 4 decades (97). Although sarcopenia occurs as a natural part of aging, over
time, muscle loss can impair the performance of activities of daily living (98), increase frailty, and
increase the likelihood of falls (99). Mediating the loss of skeletal muscle during the aging process
may require a multifaceted approach over time to address the plethora of responsible mechanisms;
however, thematically related to this review, sarcopenia may be exacerbated with the presence of
obesity.
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Insulin resistance often accompanies sarcopenic-related obesity and may atrophy muscle
fibers and dysregulate mitochondrial function, further exacerbating insulin resistance. Sarcopenia
also seems to be associated with a loss of muscular innervation, leading to a decrease in muscle
fiber cross sectional area (100). Aging adults also experience decrements in circulating hormones
such as testosterone, estrogen, and growth hormone, which may affect their ability to synthesize
muscular proteins and subsequently affects muscle mass and strength (101, 102). Sarcopenia,
especially in conjunction with obesity, has also shown to promote a pro-inflammatory physiologic
state. Pro-inflammatory cytokines and oxidative stress can decrease rates of muscle protein
synthesis (MPS), promoting a negative protein balance (103, 104).
Skeletal muscle, in conjunction with the skeletal system, is also responsible for facilitating
functional movements that provide mobility (98, 105-107). Limb movement is achieved through
neural innervations that coordinate muscular contractions and relaxations for the specific torque
required at a joint (108). Skeletal muscle size, quality, and strength all contribute to the
effectiveness of performing functional movements such as walking and running. Any reductions
in their sufficiency decreases the proficiency of accomplishing normal activities of daily living.
One possible way to increase or attenuate the loss of skeletal muscle is to target the skeletal muscle
protein synthesis pathways.

1.5

Mechanisms of muscle protein synthesis
To better understand how skeletal muscle is regulated, it is essential to understand MPS.

Muscle proteins are constantly degraded and re-synthesized in a process known as muscle protein
turnover. During this component of muscle metabolism, ~75% of endogenous amino acids that
come from breakdown are resynthesized into new muscle proteins (109). Consequently, ~25% of
dietary amino acids are incorporated into newly synthesized tissue. As discussed previously, net
protein balance is negative during the post-absorptive state to provide the necessary amino acids
for essential tissues and organs. During the postprandial state, net protein balance is positive to
replenish the muscle protein content lost during fasting (110). Additional anabolic stimuli such as
resistance training can also promote the deposition of muscle proteins and drive positive net
muscle protein balance (110). Alternatively, catabolic stimuli such as periods of inactivity deplete
muscle proteins resulting in a negative net muscle protein balance (110). Understanding the impact
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of diet and physical activity on mechanisms of muscle protein deposition/depletion is critical for
targeting strategies to preserve lean mass.
1.5.1 Overview of the mechanistic target of rapamycin pathway
Stable isotopes allow for direct measurement of labeled amino acids into newly synthesized
muscle tissue. The relationship between MPS and muscle protein breakdown determines whether
muscle proteins are ultimately deposited or depleted. When the difference between MPS and
breakdown is positive, muscle proteins are deposited, when the sum is negative, muscle proteins
are depleted. Except in highly catabolic conditions, it’s estimated that MPS has a 3-4 fold greater
influence over net protein balance than muscle protein breakdown (111-113). The following
sections will focus on reactions in the mechanistic target of rapamycin (mTOR) signaling pathway,
an intracellular pathway that is present in all human cells, mediated through dietary protein
ingestion, resistance training, and the combination of the two.
mTOR is an evolutionarily conserved threonine/serine protein kinase essential for cell
survival and protein synthesis that interacts with numerous proteins to form either mTOR complex
1 (mTORC1) or 2 (mTORC2) (114). The mTORC1 pathway is sensitive to input from amino acids,
stress, energy status, oxygen availability, and growth factors, while mTORC2 is only responsive
to growth factors (115). As this review focuses on dietary protein and amino acid ingestion, this
discussion will center on the mTORC1 pathway. The mTOR pathway can be stimulated by
extracellular ligands such as insulin-like growth factor 1 (IGF1) and insulin as well as by changes
in 5’ adenosine monophosphate-activated protein kinase (AMPK) concentrations (114). IGF1 is
released, both locally and systemically, in response to growth hormone released by the liver (116,
117). Insulin is released by the pancreas in response to feeding. Insulin or IGF1 binding to cell
receptors activates phosphatidylinositol 3-kinase (PI3K) to produce phosphatidylinositol (3,4,5)trisphosphate (PIP3) (118). PIP3 recruits protein kinase B (PKB) to the plasma membrane where
it is activated through phosphorylation. PKB in turn activates mTORC1 indirectly by
phosphorylating and inactivating tuberous sclerosis 2 (TSC2). TSC2 inactivation leads to greater
guanosine triphosphate bound to Ras homologue enriched in brain (Rheb) that in turn activates
mTORC1 (119). mTORC1 then phosphorylates ribosomal protein S6 kinase beta-1 (p70S6K),
which phosphorylates and activates ribosomal protein S6. p70S6K phosphorylation leads to its
detachment from elongation initiation factor 3 (eIF3) and this event promotes translation initiation
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of protein synthetic machinery (117). Simultaneously, initiation factor 4E-binding protein 1
(4EBP1) is phosphorylated by mTORC1 preventing its binding to elongation initiation factor 4E
(eIF-4E), releasing inhibition. This phosphorylation event enables eIF-4E to interact with
eukaryotic initiation factor 4G to form the eukaryotic initiation factor 4F complex and commence
protein translation (120). The mTOR pathway is complex and requires the coordination of several
steps to initiate translation; however, there are multitudinous opportunities for effectors such as
dietary protein sourced amino acids to influence the regulation of the mTOR pathway. There are
various other pathways that can influence mTORC1 activity that are outside the scope of this
review. The reader is directed to an excellent review that details upstream effectors of mTORC1
and the downstream regulation of lipid synthesis, lysosome biogenesis, autophagy, and energy
metabolism (121).
1.5.2 Acute effects of dietary protein ingestion on muscle protein synthesis
Sufficient dietary protein consumption upregulates the mTOR pathway and the subsequent
MPS response above basal rates (111, 122-125). Amino acids uniquely stimulate mTOR by
initiating translocation from the cytoplasm to the lysosomal surface (126). Amino acids must be
present for any signal (even ones in the TSC1/2 dependent pathway) to activate mTORC1 because
GTP- Rheb only interacts with mTORC1 when at the lysosomal surface (127). Thus, amino acids
are necessary for mTORC1 activation; other positive signals cannot override an amino acid deficit
to stimulate mTORC1. This implicates amino acids as having a particularly central role in
regulation of mTORC1-dependent promotion of skeletal muscle health. There are multiple other
mechanisms by which amino acid sufficiency may be signaled to mTORC1 (128) including
RagGTPases, mitogen-activated protein kinase 3, and the lipid kinase human vacuolar sorting
protein 34 (121). The exact mechanism by which mTORC1 senses amino acids is not currently
understood and whether the interaction is direct or indirect is still being investigated. It is clear
that amino acids act independently of TSC1/2 (121) and there is limited evidence that amino acids
may act directly on p70S6K to promote translation initiation (122). Regardless of the exact
signaling mechanism, consuming dietary protein increases MPS.
Acutely increasing the supply of isotopically labeled amino acids increases tracer
incorporation into muscle proteins (129). After consuming protein, it takes approximately 30 min
for the amino acids to be detected in the muscle and roughly 60-90 min for MPS to reach maximum
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(118, 124). Consuming complete protein sources with adequate essential amino acids better
stimulates MPS than does non-essential amino acids (130, 131). In particular, the branched-chain
amino acids leucine, isoleucine, and valine have the greatest effect on MPS rates compared to other
essential amino acids (122, 132, 133). Several animal and human studies also reported that leucine
may be the most potent stimulator of MPS out of the branched chain amino acids (134-137).
Although the exact mechanisms by which proteins and amino acids signal to the mTOR pathway
are still unknown, protein and amino acid quantity and composition are important factors that
affect MPS.
The positive association between protein quantity and MPS is not linear but has a saturable
dose response relation. MPS is dose responsive to dietary protein and amino acid consumption,
but is maximized at protein loads of ~30 g of protein or 0.24 g protein/kg body weight in younger
adults (138, 139). Notably, the time-course surrounding protein ingestion may be important when
assessing MPS. One study showed that hyperaminoacidemia or the rapid absorption of amino acids
into circulation enhances the effect of amino acids on MPS compared to composite availability of
amino acids over the testing period (140). The subsequent fall in plasma amino acid concentrations
is also necessary before another protein dose can be administered (118). The importance of the
cyclical pattern on MPS was corroborated by another study showing that when subjects consumed
eight, 10 g protein spread doses versus four, 20 g protein intermediate doses over the same time
period, there was lower composite MPS (141). Two 40-g bolus doses also had lower composite
MPS than the intermediate dosing pattern (141), which may be explained by the time-course
response of the amino acids from the meal. Theoretically, the intermediate dosing pattern allowed
for the appropriate cyclical rise and fall in plasma amino acid concentrations in addition to a more
frequent stimulation of MPS.
1.5.3 Acute effects of resistance training on muscle protein synthesis
Resistance training is characterized by the rapid succession of loaded muscular
contractions and the recruitment of type II muscle fibers (142). Repeated bouts of muscle loading
increases MPS and is associated with the phosphorylation of mTOR-related molecules (111, 123,
143). The exact mechanism by which resistance training signals to the mTOR pathway is still not
fully elucidated. One study demonstrated that the administration of rapamycin (mTORC1 inhibitor)
in humans 2 h prior to resistance training effectively reduced MPS and decreased mTORC1 and
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P70S6K1 phosphorylation 1 h after resistance training (144). P70S6K1 phosphorylation returned
to baseline after 2 h whereas 4EBP1 phosphorylation remained unchanged by rapamycin loading
during the trial period. These data suggested the presence of redundant signaling pathways to
stimulate MPS following an acute bout of resistance training. A subsequent study used rapamycinresistant mTOR mutant mice to show that rapamycin administration resulted in reduced mTORC1
signaling and muscle fiber cross sectional area (145). However, this study also showed muscular
hyperplasia after resistance training, highlighting the difference between human and rodent
physiology.
Resistance exercise acutely increases IGF1 gene expression, which indirectly increases
PKB activity (146). PKB activity also independently increases immediately after fast-twitch
muscle fiber contraction (120, 147, 148). As a downstream target of PI3K and PKB, mTORC1 is
upregulated and phosphorylates p70S6K and 4EBP1 (143, 149, 150). Whether IGF1 release
effectively augments changes in phenotype is less certain. One clinical trial had adults resistance
train either the arm muscles alone or the arm and leg muscles concurrently to induce markedly
different systemic concentrations of IGF1 (151, 152). Acute mTORC1-associated signaling, MPS,
and long term adaptations in skeletal muscle mass and strength were not differentially affected by
low (arm alone) or high (arm and leg) concentrations of circulating IGF1. These data challenge
the classical insulin-mTOR signaling pathway and corroborate the hypothesis of redundant
signaling.
Resistance training also acutely increases adenosine monophosphate concentrations,
activating AMPK (123). AMPK activation is associated with a decrease in the phosphorylation of
P70S6K1 and 4EBP1 and a decrease in MPS immediately after resistance training (120, 153).
However, 1 h to 2 h after resistance training, downstream protein phosphorylation and MPS
increased. This may be because the energy state of the cell has returned to normal and AMPK is
not inhibiting mTOR. Consistent data show that resistance training increases MPS after the initial
post-exercise period (154-161). One RCT in ten young adults showed that MPS was 69% greater
after resistance training over a 10-h period than while resting (154). Multiple studies even reported
that resistance training can stimulate MPS up to 48 h later (159, 160) and sometimes even longer
(162). Resistance training is a potent stimulator of MPS independent of protein or amino acid coingestion; however, net protein balance remains negative without precursor amino acids (113).
This highlights the need for concurrent ingestion of dietary protein to additively increase MPS
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and promote a positive net protein balance (113). For other regulators of MPS related to resistance
training, such as mechanotransduction, the reader is directed to this review (163).
1.5.4 Additive effect of acute dietary protein ingestion and resistance training on muscle protein
synthesis
The period after resistance training may be an “ideal” time to promote skeletal muscle
anabolism. Co-ingesting dietary protein during the acute post-resistance exercise period additively
increases MPS and may promote skeletal muscle accretion over time (164-167). Resistance
exercise is hypothesized to “prime” or “sensitize” the muscle to feeding and the addition of an
exogenous amino acid supply promotes muscle hypertrophy. A RCT assessed the effects of
consuming graded intakes of whey protein (0, 10, 20, or 40 g, respectively) after performing
isometric leg exercises and resting the contralateral leg on MPS rates in adults (168). Consuming
whey protein concomitant with resistance training additively improved 4-h MPS with each level
of protein intake compared to whey protein alone. These results were reproduced when essential
amino acids or leucine were given in conjunction with resistance training (165, 169, 170). Several
studies further demonstrated that changes in acute MPS in response to resistance training and
feeding are aligned with phenotypic adaptations in the skeletal muscle after repeated exposure
(151, 152, 171-177).

1.6

Strategies to preserve lean mass while undergoing weight loss

1.6.1 Effect of prolonged energy-restriction on whole body metabolism and changes in body
composition
Energy is needed to perform functional movements, maintain body temperature and
concentration gradients, and to synthesize, breakdown, and remodel existing tissues (60).
Glycolysis, the tricarboxylic acid (TCA) cycle, and electron transport chain serve as the
oxidative pathways that allow cells and tissues to collect the chemical energy released from the
breakdown of fat, carbohydrate and protein from foods. During the fed state, increases in blood
glucose concentrations alter circulating hormonal balance (insulin to glucagon concentration
ratio) and act by cascade amplification to upregulate enzymatic activity within the pathways to
process the influx of energy (178). Conversely, in the postabsorptive and fed state, hormonal
balance shifts, down-regulating glycolysis, the TCA cycle, and electron transport chain, in favor
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of gluconeogenesis, beta-oxidation, and ketogenesis to provide the requisite energy to maintain
normal bodily function (178). Over time, energy imbalance leads to an increase or decrease in
body mass depending on whether energy intake exceeds or falls short of energy expenditure,
respectively.
Adults who consume a moderately energy restricted diet (~500 kcal less than their
estimate energy requirement/d) without concurrent exercise generally experience weight loss of
about ~0.45 kg/wk comprised of 75% fat and 25% lean tissue mass (179)that can persist for up to
8-12 months (180). As this energy-restricted diet is maintained and as body mass and skeletal
muscle mass decline, so does energy expenditure (60). Body mass eventually plateau’s at a new
lower equilibrium after ~2 y and energy intake will need to be lowered to maintain weight loss
(180). Consequently, expected weight loss will always be overestimated after 8-12 months.
Furthermore, the idea that ~3500 kcal is equal ~0.45 kg of body mass ignores the possibility that
the source of energy among stores of body fat, protein, and carbohydrate may be altered by both
the extent of caloric restriction and the macronutrient composition of the diet. A shift towards fat
oxidation may decrease the magnitude of weight loss because of the greater energy density of fat
compared to protein or carbohydrate (181).
Using structural equation modeling, Kevin Hall demonstrated that at a given relative
adiposity, an increase in the level of energy restriction leads to an increase in the ratio of body
mass lost as lean mass (182). Consequently, minimally calorically restricted diets are promoted
to preserve skeletal muscle mass. Caution should also be exercised when prescribing a
calorically restricted diet using a magnitude of restriction such as “500 kcal less than their
estimate energy requirement” because of the variance in energy requirements among
participants. A 500 kcal deficit for a female may represent a ~33% reduction in energy compared
to a ~25% reduction in a male. While the magnitude of weight loss may be similar over
experimentally feasible durations (6-18 wk), it is possible that the females could lose more lean
mass as function of body mass than the males (181). Regardless of the magnitude of energy
restriction and sex of the participants, consuming a higher proportion of energy as protein may
also aid in attenuating the loss of lean mass while losing weight (183).
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1.6.2 Defining high protein within the diet
Obligatory protein (nitrogen) requirements for ~97.5% of the healthy population were
established using nitrogen balance techniques to establish the protein recommended dietary
allowance (RDA) (60). In nitrogen balance studies, subjects first complete an adaptation period to
a protein intake level for several days. After habituation, dietary nitrogen intake and nitrogen
excretion through the urine, feces, and skin are measured and repeated within subjects at multiple
protein intake levels. A meta-analysis of 19 studies and 235 adults used a linear regression model
to determine 0.8 g/kg/d (RDA) is required for 97.5% of the population to achieve nitrogen balance
(184). High protein diets are generally defined as a diet containing more protein than the RDA;
however, a lack of consensus among research studies regarding what constitutes a high protein
diet (intakes range from 1.07 g/kg/d to 1.60 g/kg/d) makes it difficult to evaluate the effects on
lean mass changes (185). A recent regression analysis found that lean mass changes were neutral
when consuming 1.0 g/kg/d: higher protein intakes were associated with greater lean mass (186).
These data indicate that 1.0 g/kg/d may be the minimum threshold for improving lean mass
retention. Another complication when assessing the effects of a high protein diet on lean mass
changes is that comparison groups in RCTs may have also consumed a high protein diet (e.g. ~1.01.2 g/kg/d) (187) making it difficult to compare the effect of a high protein diet to a normal protein
diet (~0.8 g/kg/d). Currently, no systematic review and meta-analysis evaluated the effect of
consuming the protein RDA versus greater than the RDA on changes in lean mass, regardless of
energy or resistance training status. The following section will attempt to integrate several metaanalyses and individual RCTs to assess the effects of consuming a high (> 1.0 g/kg/d) or higher
(greater than the control group) protein diet against a normal (protein RDA) or lower (less than the
intervention group) protein diet in several prominent physiologic states (energy restriction, energy
balance, and aging).
1.6.3 Evidence for consuming a higher protein diet to preserve lean mass during periods of
prolonged energy-restriction
Weight loss is usually accompanied by undesirable lean mass reductions (179, 188). One
dietary strategy to limit lean mass loss includes consuming a high-protein, energy-restricted diet
(183). The effects of a high protein diet on body composition outcomes garner a lot of interest;
however, differences in study duration, dietary control, and protein quantity used in the higher and
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lower protein diets often produce inconsistent results. In an attempt to summarize the dietary
protein literature, a meta-analysis of 24 RCTs ≥ 4 wk in duration assessed the effects of consuming
a high protein diet (mean ± SD; 1.25 ± 0.17 g/kg/d) versus a normal/lower protein diet (0.72 ±
0.09 g/kg/d) on body mass, fat mass, and lean mass changes during negative energy balance (185).
This analysis showed that consuming a high protein diet resulted in greater reductions in body
mass (standardized mean difference: -0.79 kg, 95% confidence interval: −1.50, −0.08), fat mass
(−0.87 kg; −1.26, −0.48), and greater lean mass retention (0.43 kg; 0.09, 0.78) than a normal/lower
protein diet. The reported mean intake (0.72 g/kg/d) for the standard protein group significantly
limits interpreting the results from the meta-analysis because it’s below the protein RDA (185).
Consuming above 0.8 g/kg/d may not attenuate lean mass loss but rather consuming less than 0.8
g/kg/d may result in greater lean mass decline.
A recent review proposed that there must be a sufficient difference in protein intake of ~60%
between higher and lower protein diet groups to detect differential body composition changes
(189). This may explain the discordant findings of another comparable meta-analysis of 15 RCTs
only including studies ≥ 12 months in duration. This analysis reported no differences in body mass
and body composition responses over time between high protein and standard protein diets (190).
However, the difference in protein intake between groups was ≤ 5%. Perhaps the more modest
differences in protein intake between groups explains the null results.
To address the limitation of comparing relatively higher versus lower protein intakes, a
meta-regression of 87 RCTs assessed the effects of variations in protein intakes on changes in
body weight and body composition during periods of negative energy balance (191). This study
showed that changes in body mass were not associated with protein quantity during periods 4 wk
to 12 wk in duration. Changes in fat mass trended toward 0.64% ± 0.37 greater fat mass percentage
loss when consuming > 1.06 g/kg/d (P = 0.09). Consuming a high protein diet was also associated
with 0.60 ± 0.22 kg greater lean mass compared to groups consuming < 1.05 g/kg/d. Collectively,
these data provide evidence for modest improvements in body composition from consuming a high
protein diet.
1.6.4 Evidence for consuming a higher protein diet with concurrent resistance training to
preserve lean mass during periods of prolonged energy-restriction
Concurrently resistance training while consuming a high protein diet may attenuate the loss
of lean mass during weight loss. Based on the inflection point (186) that lean mass changes in
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older adults are neutral when consuming 1.0 g/kg/d, a meta-analysis of 24 studies ≥ 8 wk in
duration of adults (> 50 y) consuming < or > 1.0 g/kg/d or < or ≥ 25% of energy as protein
combined with resistance training while in negative energy balance (192). This analysis showed
that body mass was not different between groups when protein intake was expressed as a
percentage of energy intake or grams per kilograms per day. The high protein group (≥ 25%) lost
more fat mass (weighted mean difference: -0.57 kg; 95%CI: -0.98 to -0.15) than the normal protein
group (< 25%) and had greater lean mass (0.83 kg; 0.47, 1.19) than groups consuming < 1.0 g/kg/d.
A RCT not included in the meta-analysis by Kim et al (192) assessed the effects of consuming
200% of the RDA (high protein) against the RDA (normal protein) on body composition during
negative energy balance combined with resistance training in adult women (~48 y) for 16 wk (193).
The authors reported that consuming 1.6 g/kg/d with and without resistance training had greater
reductions in body mass (mean ± SEM: -9.3 ± 0.8 kg) and fat mass (-7.3 ± 0.8 kg) than consuming
0.8 g/kg/d (body mass: -7.3 ± 0.5 kg; fat mass: -5.3 ± 0.3 kg). Furthermore, the normal and high
protein diet groups undergoing resistance training had significantly greater lean mass than the high
and normal protein, non-resistance training groups. Notably, the high protein group undergoing
concurrent resistance training was the only group that did not lose lean mass during the
intervention. The strength of the meta-analysis (192) and RCT (193) are that the daily protein
intakes for the standard protein groups are 0.79 and 0.80 g/kg/d, respectively. The greater lean
mass could be attributed to the high protein diets and not to lean mass loss from a protein intake
below the RDA. These results add evidence that resistance training is important for attenuating
lean mass loss and that concurrently consuming > 1.0 g /kg/d may be beneficial.

1.7

Within-day protein distribution: an alternative approach to more protein?
Consuming a high protein diet may attenuate the loss of lean mass during periods of

intentional weight loss (183). Long-term adoption of a high protein diet can be challenging,
especially over periods > 12 months (194). Notably, consuming a high protein diet typically
requires consuming more protein than the average adult consumes on a daily basis (195).
According to NHANES data, adults typically consume protein in a skewed manner throughout the
day (195). Breakfast is characterized by low protein-containing foods such as coffee, cereal with
milk, or toast. Conversely, the dinner meal is traditionally the largest energy- and proteincontaining meal, usually focused around an animal protein source such as beef, pork, or chicken.
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Each meal typically provides ~13, ~20, and ~45-60 g of protein, respectively (195, 196). Since
dinner already contains a relatively high quantity of protein, a possible consequence of increasing
total daily protein intake would be to increase the protein quantity at breakfast and lunch. Acute
stable isotope enriched amino acid studies estimated that ~30 g or 0.24 g/kg/d of protein may be
required to maximally stimulate MPS (139, 197). This means that breakfast and lunch contain
insufficient protein for a maximal MPS response and dinner contains more protein than required.
Redistributing protein from the dinner meal to breakfast and lunch may improve daily composite
MPS and aid in lean mass retention (198, 199). Adults undergoing weight loss or aging adults may
only need to redistribute protein intake which may alleviate the need to increase total protein intake.
1.7.1 Observational evidence for the protein distribution concept
In support of the even protein distribution concept, an analysis of over 1,000 adults aged
50-85 y from the 1999-2002 NHANES showed that more frequent consumption of meals with ≥
30 g protein was associated with greater leg lean mass (200). Importantly, the reference group was
consuming 0.64 g/kg/d, which is less than the recommended dietary allowance for protein (0.8
g/kg/d). Conversely, the comparator groups (groups consuming 1 and 2 meals/d containing ≥ 30 g
protein) had a relative protein intake of 1.1 and 1.4 g/kg/d, respectively. These results (200)
perhaps more accurately reflect the consequences of consuming less than the recommended dietary
allowance for protein on lean mass quantity and not the benefits of evenly distributing protein
intake. The ensuing NuAge study (Quebec Longitudinal Study on Nutrition as a Determinant of
Successful Aging), a longitudinal cohort study, also characterized the effect of protein distribution
on lean mass after a 2-y follow up in both older men and women (201). The NuAge study showed
that an even protein distribution was associated with greater lean mass in both older men and
women at baseline and after follow-up (201). However, changes in lean body mass over the 2-y
observational period were not different between the even and skewed distributions groups.
Importantly, changes in lean mass occur slowly. Consequently, 2 y may not be adequate time to
assess differences in lean mass, especially using dual energy X-ray absorptiometry. These data
(201) are intriguing in that they may represent what effect long term adoption of an even or skewed
protein intake distribution has on lean mass prior to the age related loss of lean mass; assuming
the three-day dietary assessments are reflective of habitual protein distribution.
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1.7.2 Acute evidence for the protein distribution concept
There are a paucity of acute studies that assess the impact of within-day protein distribution
on daily MPS rates (198, 199, 202) and even fewer that compare higher to lower protein intake
quantity (202). The initial study was completed in young adults in energy balance and
demonstrated that evenly consuming protein (30 g at breakfast, lunch, and dinner) resulted in a 25%
greater 24-h MPS rate than consuming a skewed distribution (10 g at breakfast, 15 g at lunch, and
60 g at dinner) with the same amount of total daily protein (198). Subsequent research was
inconsistent with the initial within-day protein distribution study (199, 202). One study with older
adults, also in energy balance, showed that consuming an even protein distribution did not have a
differential effect on daily whole body protein synthesis than consuming an uneven distribution
(202). The authors (202) attributed the inconsistent results primarily to a difference in the study
population (older adults versus. younger adults) and the age-associated blunting of the postprandial
MPS response to protein ingestion (203). However, there were only 5 and 6 subjects in the groups
consuming an even and uneven protein distribution, respectively. Visually, the magnitude of the
difference between protein synthesis in the even and uneven groups appears similar to the initial
study (198), but high variability and low subjects numbers may have contributed to the null
findings (202). A subsequent study also reported no effect of protein distribution on MPS rates in
older adults in energy balance (199). This same group (199) also measured daily MPS in energy
restriction with and without resistance training. They reported that a balanced protein distribution
(25 g at breakfast, lunch, and dinner) resulted in a 19% greater 13-h MPS rate than a skewed
protein distribution (10 g at breakfast, 15 g at lunch, and 50 g at dinner) irrespective of resistance
training (199).

1.8

Conclusions
Obesity continues to be a major public health concern and may increase the risk for

developing chronic diseases such as cardiovascular diseases, T2D, and certain types of cancers.
While there are various methods of weight loss such as surgery and pharmacotherapy, behavior
and lifestyle interventions remain the most popular despite the poor long term success. Intentional
weight loss mediated through dietary energy restriction is one popular approach. One strategy is
to manipulate the macronutrient composition of the diet, which may improve the magnitude of

23
weight loss or aid in lean mass retention. Indeed, a plethora of research has gone into assessing the
effect of consuming high protein intake within the diet; however, results are still inconsistent based
on study duration, population, and protein quantity used. Regardless, long term adoption of a diet
that is drastically different from the habitual diet is difficult to adhere to. Redistributing dietary
protein intake has emerged as one possible modifier of protein intake that may alleviate the
challenges of consuming higher protein and aid in lean mass retention. However, limited data exist
to support the impact of the protein distribution concept in the modulation of lean mass retention.

1.9

Research purpose
The purpose of the research presented in this document was to first assess the impact of

protein distribution on lean mass and skeletal muscle retention after 16 wk of energy restriction
in overweight and obese adults resistance training (Study 1). The purpose of the subsequent
randomized crossover design was to investigate whether supplementing protein two hours after a
low protein-containing breakfast could preserve plasma amino acid availability compared to a
high protein-containing breakfast (Study 2). The final study was a systematic review of literature
to qualitatively assess the impact of consuming a protein supplement with or between meals on
body composition in adults > 19 y (Study 3).

1.10
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2.1

Abstract

Background: Emerging research suggests that redistributing total protein intake from 1 highprotein meal/d to multiple moderately high-protein meals improves 24-h muscle protein synthesis.
Over time, this may promote positive changes in body composition.

Objective: We sought to assess the effects of within-day protein intake distribution on changes in
body composition during dietary energy restriction and resistance training.

Design: In a randomized parallel-design study, 41 men and women [mean ± SEM age: 35 ± 2 y;
body mass index (in kg/m2): 31.5 ± 0.5] consumed an energy-restricted diet (750 kcal/d below the
requirement) for 16 wk while performing resistance training 3 d/wk. Subjects consumed 90 g
protein/d (1.0 ± 0.03 g/kg/d, 125% of the Recommended Dietary Allowance, at intervention week
1) in either a skewed (10 g at breakfast, 20 g at lunch, and 60 g at dinner; n = 20) or even (30 g
each at breakfast, lunch, and dinner; n = 21) distribution pattern. Body composition was measured
pre- and postintervention.
Results: Over time, whole-body mass (least-squares mean ± SE: −7.9 ± 0.6 kg), whole-body lean
mass (−1.0 ± 0.2 kg), whole-body fat mass (−6.9 ± 0.5 kg), appendicular lean mass (−0.7 ± 0.1
kg), and appendicular fat mass (−2.6 ± 0.2 kg) each decreased. The midthigh muscle area (0 ± 1
cm2) did not change over time, whereas the midcalf muscle area decreased (−3 ± 1 cm2). Withinday protein distribution did not differentially affect these body-composition responses.

Conclusion: The effectiveness of dietary energy restriction combined with resistance training to
improve body composition is not influenced by the within-day distribution of protein when
adequate total protein is consumed. This trial was registered at clinicaltrials.gov as NCT02066948.

2.2

Introduction
Health-promoting weight loss strategies typically are designed to produce positive changes

in body composition, including fat mass loss and the preservation of lean body mass (1). Higher
total dietary protein intakes (1.2–1.5 g/kg/d) help preserve lean mass and improve body
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composition during weight loss in young, middle-aged, and older adults (2–6). During the past
decade, within-day distribution of dietary protein has emerged as a possible modifier of body
composition and skeletal muscle size (7–9). The concept is to redistribute daily total protein intake
from mostly being consumed at 1 high-protein meal (skewed distribution) to being evenly
consumed at 3 moderate-protein meals (7). One specific within-day protein distribution strategy
promoted in the scientific (10), clinical (11), and lay-public literature is to evenly divide 90 g
protein/d between three 30-g protein meals. Currently, the scientific foundation for
recommendations to evenly distribute daily protein intake between 3 meals comes mainly from
short-term feeding studies utilizing protein supplements (12) or lean beef (10), which included
measurements of muscle protein synthesis (MPS) rates. The initial study reported that evenly
redistributing daily protein into multiple moderately high-protein meals resulted in a 25% greater
(faster) 24-h MPS rate than a skewed protein distribution (10). Subsequent research also reported
a 19% greater MPS rate after a 13-h period with even or skewed protein intake (12). Collectively,
these early results suggest that daily MPS rates are greater when meal-to-meal protein intake is
evenly distributed, compared with a typical skewed protein intake that contains only 1 much largerprotein meal/d.
Theoretically, a greater daily MPS rate will positively affect body composition over time
(13), particularly in situations in which there may be an increased risk of a reduction in lean body
mass. Dietary energy restriction is a robust catabolic stimulus that reduces fat mass and usually
reduces lean mass and muscle size (14–16). Alternatively, resistance training is an anabolic
stimulus that increases the rate of MPS (17–20) and promotes increases in lean mass, including
skeletal muscle (21). Currently, a paucity of longitudinal research studies exist that critically assess
whether within-day protein distribution helps retain lean body mass during periods of purposeful
weight loss when consumed within the context of practical dietary patterns utilizing whole foods.
The aim of this study was to assess the effects of within-day protein intake distribution during
dietary energy restriction on changes in lean body mass and midthigh muscle area while resistance
training. We hypothesized that evenly distributing daily protein intake with concurrent resistance
training would result in the retention of lean body mass during periods of energy restriction
compared with skewing protein intake. The even within-day protein distribution may offer adults
who are overweight or obese another dietary strategy to improve their body composition during
intentional weight loss without altering total protein intake.
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2.3

Method

2.3.1 Experimental design
This 18-wk study included a 2-wk baseline testing period, followed by a 16-wk randomized
controlled intervention period (Appendix A Table 1). During the intervention period, all subjects
consumed a controlled, energy-restricted diet and participated in a progressive overload resistance
training program. Each subject was randomly assigned (using an online randomization plan
generator; http://www.randomization.com/) to 1 of 2 dietary groups and was instructed to consume
meal-specific foods and beverages to achieve an even or skewed within-day protein distribution
(EVEN or SKEW, respectively). The clinical laboratory manager, J Green, who was not involved
in data collection or analysis, generated the random allocation sequence and assigned subjects to
the intervention. Postintervention testing was completed during intervention week 16. All subjects
were instructed to maintain their habitual types and levels of physical activities aside from the
prescribed resistance training.
2.3.2 Subjects
Fifty-eight adults recruited from the greater Lafayette, Indiana, community provided
written consent before participation. This study was conducted between January 2014 and
November 2015 and was stopped after recruitment goals were met. Study inclusion criteria were
as follows: age 19–50 y, BMI (in kg/m2) of 27.0–34.9, stable weight (±4.5 kg during previous 3
mo), nonsmoking status, not diabetic, no acute illness, not pregnant or lactating, ability to exercise,
not claustrophobic and able to complete MRI testing, and willing and able to travel to testing
facilities. The study protocol and all study documents were approved by the Purdue University
Biomedical Institutional Review Board. This study was registered at clinicaltrials.gov as
NCT02066948.
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Fifty-four subjects completed all baseline testing and started the intervention, whereas 4
subjects (EVEN, n = 2; SKEW, n = 2) dropped out before starting the intervention because of
personal conflicts with the menu (n = 3) or a scheduling conflict (n = 1). Thirteen subjects left the
study during the intervention period (EVEN, n = 7; SKEW, n = 6) for personal reasons (n = 5),
time commitment (n = 2), noncompliance with the menu (n = 3), noncompliance with exercise (n
= 1), medication change (n = 1), or pregnancy (n = 1). Forty-one subjects [EVEN: n = 21 (6 men
and 15 women); SKEW: n = 20 (9 men and 11 women); race-ethnicity: African American, n = 1;
Asian/Pacific Islander, n = 2; and Caucasian, n = 38] completed all study procedures and their data
were analyzed (Figure 2.1).

Figure 2.1 Study recruitment flow diagram.
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2.3.3 Diet Intervention
Each subject’s total energy requirement was estimated before the study through the use of
sex-specific equations for overweight or obese adults with a low activity level (physical activity
coefficients were 1.12 for men and 1.16 for women) (22). Throughout the intervention period, each
subject consumed a diet providing 750 kcal/d less than their estimated energy requirement. The
diets consisted of a 1400 kcal/d base diet that contained 90 g protein, 40 g fat, and 170 g
carbohydrate (i.e., a 35–65% ratio of nonprotein energy intake from fat and carbohydrate) and
were designed so that all foods were consumed at breakfast, lunch, and dinner. Additional fat and
carbohydrate was added to each subject’s daily intakes, as necessary, to achieve his or her
individualized energy allowance while maintaining the 35–65% fat-to-carbohydrate ratio. For all
subjects, the prescribed within-day distribution of total energy intake was ∼20% breakfast, 30%
lunch, 36% dinner, and 14% snacks, respectively. The prescribed within-day protein distributions
of the 2 groups were as follows: 1) EVEN: 30, 30, and 30 g protein/meal consumed at breakfast,
lunch, and dinner, respectively, and 2) SKEW: 10, 20, and 60 g protein/meal, respectively. Foods
consumed as snacks contained minimal protein. Dietary protein sources are listed in Appendix A
Table 2. The individualized menus were developed by A Wright, a registered dietitian, using
ProNutra software (Viocare Inc.). The within-day energy and protein distributions of the SKEW
pattern were consistent with NHANES distributions (8).
A digital platform scale (model ES200L; Ohaus Corporation) was used to measure body
mass at baseline and once weekly during the intervention period. If body mass loss was <0.5 kg/wk
for 2 consecutive weeks, the subject’s energy intake was lowered by reducing nonprotein energy
intake. At baseline, each subject’s 24-h food intakes were assessed for energy and macronutrient
contents using a 3-d food record (Nutrition Data System for Research software, version 2014;
Nutrition Coordinating Center, University of Minnesota). Salting and herbal seasoning of food,
water, and non–energy, caffeine-containing beverages were allowed ad libitum during the
intervention. Subjects were provided with a digital food scale (Salter Microtronic Electronic
Kitchen Scale) to aid in measuring portion sizes. All diet-related activities and assessments were
performed in conjunction with the Indiana Clinical Research Center Bionutrition Facility at Purdue
University.
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2.3.4 Dietary Compliance
During the intervention, dietary compliance was assessed through the use of daily menu
checklists and periodic pre- and postmeal date- and time-identified photography. The study
dietitian and other research staff members also contacted subjects weekly in person, by E-mail,
and by phone to encourage compliance with the prescribed menus. See Appendix A Table 3 for
more information about dietary compliance measures.
2.3.5 Resistance training
All subjects performed 3 sets of resistance exercises on 3 nonconsecutive days per week.
The exercises included the seated chest press, seated upper back row, seated bilateral leg extension,
seated bilateral angled leg presses and seated bilateral leg curl (core exercises) and 2 additional
auxiliary exercises (Technogym). The hip abductor and seated shoulder press exercises were
alternated every other training session with the latissimus dorsi pull down and hip adductor
exercises. The first set for each exercise was completed in 8–10 repetitions, with the last 2 sets
completed to volitional fatigue. In weeks 1, 2, and 3–16 of the intervention, subjects performed
each exercise at 60%, 70%, and 80% of their most recently measured 1-repetition maximum,
respectively. Each training session was supervised, lasted ∼1 h, and included 10-min warm-up and
cool-down periods consisting of low-intensity aerobic exercise and stretching.
During baseline and every fourth week, 1-repetition maximum testing was performed to
measure subjects’ maximal strength on the 5 core exercises. Measurements were taken on the same
machines used for training. Whole body strength was considered the sum of the 1 repetition
maximums for 4 core exercises. The seated bilateral angled leg press core exercise was removed
from the analysis of composite whole body strength because the subject's strength often exceeded
the machine's available resistance. Further details regarding the resistance training protocol are
listed in Appendix A Table 3.
2.3.6 Resistance training compliance
At baseline and intervention week 16, fasting state whole body mass, fat mass, and soft
tissue lean mass were measured with dual-energy X-ray absorptiometry (GE Lunar Prodigy with
version 11.1 enCORE iDXA software). Procedures are detailed in Appendix A Table 2. We used
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MRI (3T General Electric Signa HDx system) to measure the right midthigh and calf muscle areas
for cross-sectional area, muscle area, subcutaneous fat area, and intramuscular adipose tissue
(IMAT) area. See Appendix A Table 3 for more information on MRI procedures and image
processing.
2.3.7 Body composition
At baseline and intervention week 16, fasting state whole body mass, fat mass, and soft
tissue lean mass were measured with dual-energy X-ray absorptiometry (GE Lunar Prodigy with
version 11.1 enCORE iDXA software). Procedures are detailed in Appendix A Table 3. We used
MRI (3T General Electric Signa HDx system) to measure the right midthigh and calf muscle areas
for cross-sectional area, muscle area, subcutaneous fat area, and intramuscular adipose tissue
(IMAT) area. See Appendix A Table 3 for more information on MRI procedures and image
processing.
2.3.8 Statistical analysis
Analyses were completed with data from the 41 subjects who finished the intervention. To
reflect that subject age and sex were used as covariates, all results are presented as least-squares
means ± SEs unless otherwise stated. The main effect of time and group-by-time interactions were
assessed with a 2 × 2 factor repeated-measures ANOVA (SAS MIXED procedure; group: EVEN,
SKEW; time: pre- and postintervention). Group-by-time interactions were the effect of within-day
dietary protein distribution (group) from pre- to postintervention (time). We used an unpaired, 2tailed t test (SAS TTEST procedure) to test for group differences in preintervention age and height
and in the percentages of postintervention menu checklist compliance, meal picture compliance,
and resistance training compliance. Statistical significance was determined at P < 0.05. Statistical
analysis was performed with SAS software (version 9.3; SAS Institute).

2.4

Results

2.4.1 Subjects
At baseline, age, body proportions, body composition, and maximal muscle strength
characteristics were not significantly different between the EVEN and SKEW groups (Table 2.1).
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There was only one adverse event: one subject fainted during resistance training. This adverse
event was medically and administratively resolved.
2.4.2 Diet intervention
At baseline, habitual protein intake in the EVEN (15 ± 4, 30 ± 3, and 31 ± 5 g of protein at
breakfast, lunch, and dinner, respectively; total protein intake: 82 ± 4 g/d) and SKEW (15 ± 2, 31
± 4, and 39 ± 5 g protein/meal; 90 ± 4 g/d) groups were not different. The 90 g protein/d intake
prescribed throughout the 16-wk intervention period equated to 1.0 ± 0.04 and 1.0 ± 0.04 g/kg/d
at intervention week 1 and 1.1 ± 0.04 and 1.1 ± 0.04 g/kg/d at intervention week 16 for the EVEN
and SKEW groups, respectively (Appendix A Table 4). The apparent increase in protein intake at
week 16 was attributable to differences in week 1 compared with week 16 body masses. Week 16
menu checklists indicated that the EVEN group consumed 31 ± 0, 29 ± 0, and 29 ± 0 g of protein
at breakfast, lunch, and dinner, respectively (Appendix A Table 4). The SKEW group consumed
11 ± 0, 20 ± 0, and 59 ± 0 g of protein at breakfast, lunch, and dinner, respectively (Appendix A
Table 5). Subjects in the EVEN and SKEW groups were deemed compliant to their respective
diets 80 ± 4% and 82 ± 3%, respectively, of 54 meals visually assessed with photography and 92
± 2% and 88 ± 2%, respectively, of 294 meals assessed with menu checklists (Appendix A Table
6).
2.4.3 Resistance training intervention
Resistance training compliance was >85% for both groups but was statistically lower for
the EVEN group than the SKEW group, averaging 41 (86.0 ± 1.6%) and 43 (91.0 ± 1.5%) of 48
resistance training sessions, respectively (Appendix A Table 6). Whole body strength increased by
∼20% in each group, independent of protein distribution (Table 2.1).
2.4.4 Body composition
Within-day dietary protein distribution did not influence responses over time for the whole
body and muscle-specific outcomes (Table 2.1). Over time, whole-body mass (−7.9 ± 0.6 kg), BMI
(−2.7 ± 0.2), whole-body lean mass (−1.0 ± 0.2 kg), whole-body fat mass (−6.9 ± 0.5 kg), fat mass
percentage (−4.6 ± 0.4%), lean mass index (−0.3 ± 0.1 kg/m2), fat mass index (−2.3 ± 0.2 kg/m2),
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appendicular lean mass (−0.7 ± 0.1 kg), appendicular fat mass (−2.6 ± 0.2 kg), waist circumference
(−8.8 ± 0.7 cm), hip circumference (−6.6 ± 0.6 cm), and waist:hip ratio (−0.03 ± 0.01) each
decreased and lean mass percentage (4.3 ± 0.4%) increased (main effects of time, P < 0.0001).
Total midthigh area (−28 ± 3 cm2), midthigh subcutaneous fat area (−27 ± 2 cm2), and
IMAT area (−1 ± 0 cm2) decreased, independent of protein distribution (main effects of time, P <
0.0001). Midthigh muscle area (0 ± 1 cm2) did not change from pre- to postintervention (main
effect of time, P = 0.797). Total midcalf area (−8 ± 1 cm2), midcalf muscle area (−3 ± 1 cm2),
subcutaneous fat area (−4 ± 1 cm2), and IMAT area (−3 ± 1 cm2) decreased from pre- to
postintervention (main effects of time, P < 0.0001).

Table 2.1 Subject’s changes in anthropometrics, body composition, and whole body strength in the EVEN and SKEW groups after consuming an energyrestricted diet and performing resistance training for 16 wk
EVEN

SKEW

P-value

Pre

Post

Change

Pre

Post

Change

Time

GxT

33 ± 2

—

—

36 ± 2

—

—

—

—

Height1,3 (cm)

170.5 ± 1.7

—

—

173.1 ± 1.9

—

—

—

—

Body mass2,3 (kg)

95.9 ± 2.3

87.2 ± 2.3

-8.6 ± 0.9

92.8 ± 2.3

85.5 ± 2.3

-7.3 ± 0.9

<0.001

0.320

BMI2,3 (kg/m2)

31.9 ± 0.5

29.0 ± 0.5

-2.9 ± 0.3

30.8 ± 0.5

28.3 ± 0.5

-2.4 ± 0.3

<0.001

0.274

Waist circumference2,4
(cm)

104.6 ± 1.8

95.4 ± 1.8

-9.1 ± 1.0

102.6 ± 1.8

94.2 ± 1.8

-8.4 ± 1.1

<0.001

0.601

Hip circumference2,5 (cm)

114.5 ± 1.5

107.6 ± 1.5

-6.9 ± 0.8

112.5 ± 1.5

106.3 ± 1.5

-6.3 ± 0.9

<0.001

0.599

Waist:Hip2,4

0.91 ± 0.01

0.89 ± 0.01

-0.03 ± 0.01

0.91 ± 0.01

0.89 ± 0.01

-0.03 ± 0.01

<0.001

0.996

Lean mass (kg)

55.8 ± 1.2

54.2 ± 1.2

-1.5 ± 0.4

54.1 ± 1.2

53.6 ± 1.2

-0.5 ± 0.4

<0.001

0.067

Lean mass (%)

57.8 ± 1.0

61.9 ± 1.0

4.1 ± 0.5

58.1 ± 1.0

62.6 ± 1.0

4.5 ± 0.5

<0.001

0.576

Fat mass (kg)

36.9 ± 1.6

29.9 ± 1.6

-7.1 ± 0.7

35.7 ± 1.6

28.9 ± 1.6

-6.8 ± 0.7

<0.001

0.789

Fat mass (%)

38.8 ± 1.1

34.4 ± 1.1

-4.4 ± 0.5

38.6 ± 1.1

33.9 ± 1.1

-4.7 ± 0.5

<0.001

0.640

18.4 ± 0.3

17.9 ± 0.3

-0.5 ± 0.1

17.8 ± 0.3

17.6 ± 0.3

-0.2 ± 0.1

<0.001

0.066

12.4 ± 0.5

10.0 ± 0.5

-2.4 ± 0.2

12.0 ± 0.5

9.7 ± 0.5

-2.3 ± 0.2

<0.001

0.695

1.6 ± 0.1

1.9 ± 0.1

0.3 ± 0.1

1.6 ± 0.1

2.1 ± 0.1

0.4 ± 0.1

<0.001

0.281

Parameters
Age1,3 (y)

Whole body2,3

Lean mass index
(kg/m2)
Fat mass index
( kg/m2)
Lean mass:fat mass
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Table 2.1 Continued. Subject’s changes in anthropometrics, body composition, and whole body strength in the EVEN and SKEW groups after consuming an
energy-restricted diet and performing resistance training for 16 wk
EVEN

SKEW

P-value

Pre

Post

Change

Pre

Post

Change

Time

GxT

Total mass

43.3 ± 1.1

39.7 ± 1.1

-3.5 ± 0.4

42.2 ± 1.1

39.0 ± 1.1

-3.1 ± 0.4

<0.001

0.498

Lean mass

26.4 ± 0.7

25.5 ± 0.7

-1.0 ± 0.2

25.7 ± 0.7

25.1 ± 0.7

-0.5 ± 0.2

<0.001

0.169

Fat mass

15.3 ± 0.8

12.7 ± 0.8

-2.6 ± 0.3

15.1 ± 0.7

12.4 ± 0.7

-2.7 ± 0.3

<0.001

0.917

Total mass

16.3 ± 0.5

15.0 ± 0.5

-1.3 ± 0.2

16.0 ± 0.4

14.8 ± 0.4

-1.2 ± 0.2

<0.001

0.594

Lean mass

10.0 ± 0.3

9.6 ± 0.3

-0.4 ± 0.1

9.7 ± 0.2

9.5 ± 0.2

-0.2 ± 0.1

<0.001

0.186

Fat mass

5.7 ± 0.3

4.8 ± 0.3

-1.0 ± 0.1

5.8 ± 0.3

4.7 ± 0.3

-1.0 ± 0.1

<0.001

0.691

Total cross section

308 ± 11

277 ± 11

-31 ± 4

288 ± 11

263 ± 11

-25 ± 4

<0.001

0.253

Muscle

158 ± 5

155 ± 5

-2 ± 2

146 ± 4

147 ± 4

2±2

0.797

0.136

Subcutaneous fat

121 ± 11

104 ± 11

-28 ± 3

124 ± 11

100 ± 11

-25 ± 3

<0.001

0.515

10 ± 1

9±1

-1 ± 0

10 ± 1

9±1

-1 ± 0

<0.001

0.829

Parameters
Appendicular2,3 (kg)

Right leg2,3 (kg)

Right mid-thigh area2,6
(cm2)

IMAT
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Table 2.1 Continued. Subject’s changes in anthropometrics, body composition, and whole body strength in the EVEN and SKEW groups after consuming an
energy-restricted diet and performing resistance training for 16 wk
EVEN

SKEW

P-value

Pre

Post

Change

Pre

Post

Change

Time

GxT

Cross section

126 ± 3

118 ± 3

-9 ± 1

123 ± 4

116 ± 4

-7 ± 1

<0.001

0.452

Muscle

79 ± 3

76 ± 3

-4 ± 1

78 ± 3

76 ± 3

-3 ± 1

<0.001

0.444

Subcutaneous fat

32 ± 3

28 ± 3

-4 ± 1

31 ± 3

277 ± 3

-4 ± 1

<0.001

0.806

IMAT

14 ± 1

10 ± 1

-3 ± 1

9±1

7±1

-2 ± 0.0

<0.001

0.375

Parameters
Right mid-calf area2,6
(cm2)

Strength2,7 (kg)
Whole body
511 ± 22
625 ± 24
114 ± 17
535 ± 22
630 ± 24
95 ± 19
<0.001
0.470
1
Data are presented as means ± SEM; An unpaired, two tailed t-test (TTEST procedure, SAS version 9.3; SAS Institute) was used to test for differences
between groups in pre-intervention age and height and were not different.
2
Data are presented as LSmean ± SE of the LSmean; A repeated-measure ANOVA (MIXED procedure, SAS version 9.3; SAS Institute) was used to test for
main effect of time and group-by-time interaction. No significant group-by-time interactions for the measured variables were observed between the EVEN and
SKEW groups
3
EVEN: n= 6 males and 15 females, SKEW: 9 males and 11 females
4
Pre: EVEN: n= 6 males and 15 females, SKEW: 9 males and 11 females; Post: EVEN: n= 6 males and 15 females, SKEW: 7 males and 11 females
5
Pre: EVEN: n= 6 males and 15 females, SKEW: 9 males and 11 females; Post: EVEN: n= 6 males and 15 females, SKEW: 8 males and 11 females
6
Pre: EVEN: n= 6 males and 15 females, SKEW: 9 males and 10 females; Post: EVEN: n= 6 males and 14 females, SKEW: 7 males and 10 females
7
Pre: EVEN: n= 5 males and 15 females, SKEW: 7 males and 11 females; Post: EVEN: n= 2 males and 12 females, SKEW: 4 males and 8 females
Abbreviations: EVEN, 30 g of protein consumed at breakfast, lunch, and dinner; SKEW, 10 g of protein consumed at breakfast, 20 g at lunch, and 60 g at
dinner; Waist:hip, waist to hip ratio; IMAT, intramuscular adipose tissue; Whole body strength, sum of the 4 core exercises; G x T, group-by-time interaction.
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2.5

Discussion
To our knowledge, this study is the first randomized controlled trial to use strict dietary

and resistance training controls to assess the efficacy of consuming an even or skewed protein
distribution on changes in whole body lean mass during energy restriction while resistance training.
Contrary to our hypothesis, distributing daily protein intake evenly between 3 meals (30 g at
breakfast, lunch, and dinner) compared with a more typical skewed distribution pattern (10 g at
breakfast, 20 g at lunch, and 60 g at dinner) does not influence body composition responses in
adults undergoing purposeful weight loss and resistance training.
To our knowledge, before we initiated the current study, only one study had assessed the
effects of within-day protein distribution on MPS (10). This study was completed in young adults
in energy balance and demonstrated that evenly consuming protein (30 g at breakfast, lunch, and
dinner) resulted in a 25% greater 24-h MPS rate than consuming a skewed distribution (10 g at
breakfast, 15 g at lunch, and 60 g at dinner) with the same amount of total daily protein (10). Since
we initiated the current study, subsequent research has shown inconsistent results regarding withinday protein distribution and MPS (12, 23). One study with older adults, also in energy balance,
showed that consuming an even protein distribution did not have a differential effect on the daily
whole body protein synthesis rate compared with consuming an uneven distribution (23). The
authors (23) attributed the inconsistent results primarily to a difference in the study population
(older adults compared with younger adults) and the age-associated blunting of the postprandial
MPS response to protein ingestion (24). Other possibilities include the quantity of protein
consumed per meal and whether the protein was contained in whole foods (23) or supplements
(12). These factors are associated with alterations in protein digestion and amino acid absorption
kinetics. It may be that even greater protein intakes per meal are required within the context of
mixed-nutrient meals. A subsequent study also reported no effect of protein distribution on MPS
rates in older adults in energy balance (12). The protein intake at each meal was ∼0.26 g/kg, well
below the estimated requirement of 0.4 g/kg/meal for older adults to maximally stimulate MPS
(25). More applicable to the current study, this same group (12) also measured daily MPS in energy
restriction with and without resistance training. They reported that a balanced protein distribution
(25 g at breakfast, lunch, and dinner) resulted in a 19% greater 13-h MPS rate than a skewed
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protein distribution (10 g at breakfast, 15 g at lunch, and 50 g at dinner) irrespective of resistance
training (12). Although relating these acute MPS results to the current null lean mass result is
problematic, one possibility is that measurements of MPS do not directly translate to changes in
long-term lean mass homeostasis (26).
A second possibility for the null body composition results may be that the quantity of
protein prescribed at each meal between the EVEN and SKEW groups was not sufficiently
different to detect a measurable effect of protein distribution on lean body mass changes. Highquality protein sources including pork, egg, beef, and dairy were prescribed at breakfast, lunch,
and dinner during the intervention. When these types of high-quality protein sources are consumed,
the maximal MPS response is estimated to be reached at doses of 0.24 g/kg (25). According to the
menu checklists, the SKEW group consumed ∼20 and ∼60 g of high-quality protein at lunch and
dinner, respectively. This is equivalent to ∼0.24 g/kg at lunch and ∼0.71 g/kg at dinner, both of
which are hypothesized to be adequate quantities of protein to maximize the MPS response in
young adults (25). Consequently, the SKEW group may have consumed 2 meals (lunch and dinner)
that provided sufficient protein to maximize MPS. It may be that a slightly lesser MPS rate at 1
meal (breakfast) does not substantially affect lean body mass enough to be detectable given our
study design.
A third possibility for the null body composition results is that consuming an even protein
distribution did not promote greater daily MPS. A recent analysis estimated that 0.24 g/kg is
needed to maximally stimulate MPS in younger adults (25). In the present study, the per-meal dose
for the EVEN distribution was 30 g within the context of mixed-nutrient meals. We provided more
than enough protein to meet this threshold (∼0.3 g/kg/meal) plus a “safety margin” of ∼0.1
g/kg/meal. However, the 0.24 g/kg/meal estimates are based on studies that used isolated intact
proteins. Perhaps the protein quantity within mixed-nutrient meal needs to be greater than when a
protein supplement is consumed alone. Mixed-nutrient meals inherently contain a mix of protein
qualities and have altered protein digestion kinetics and amino acid availabilities compared with
isolated intact proteins from protein supplements. It may be that the EVEN group did not consume
adequate protein at each meal to maximally stimulate MPS, whereas the SKEW group met the
protein dose needed to maximally stimulate MPS at dinner. This may be evident in our lean body
mass outcome showing a trend (P = 0.067) for greater lean body mass retention in the SKEW
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group than the EVEN group. Indeed, other studies showed that consuming ≥1 meal that
theoretically maximizes MPS may be better for lean body mass retention than consuming 3 evenly
distributed meals that are “protein insufficient” (27, 28).
Observational assessments of the influence of within-day protein distribution on lean mass
in humans also contribute to the body of literature. In support of the even protein distribution
concept, an analysis of >1000 adults aged 50–85 y from the 1999–2002 NHANES showed that
more frequent consumption of meals with ≥30 g protein was associated with greater leg lean mass
(8). Importantly, the reference group was consuming 0.64 g/kg/d, which is less than the
Recommended Dietary Allowance for protein (0.8 g/kg/d). Conversely, the comparator groups
(groups consuming 1 and 2 meals/d containing ≥30 g of protein) had a relative protein intake of
1.06 and 1.4 g/kg/d, respectively. These results (8) may reflect the consequences of consuming
less than the Recommended Dietary Allowance for protein on lean body mass quantity and not the
benefits of evenly distributing protein intake. The ensuing NuAge study (Quebec Longitudinal
Study on Nutrition as a Determinant of Successful Aging), a longitudinal cohort study, also
characterized the effect of protein distribution on lean mass after a 2-y follow-up in both older men
and women (13). The NuAge study showed that an even protein distribution was associated with
greater lean mass in both older men and women at baseline and after follow-up. However, changes
in lean body mass over the 2-y observational period were not different between the even and
skewed distribution groups (13). Perhaps protein distribution does not affect lean body mass,
which is in agreement with the results of the present study. However, questions regarding statistical
power and group sample size for both the NuAge study and the current study underscore the
importance of new research with larger sample sizes and longer durations to investigate potential
influence of protein distribution on changes in lean body mass.
In summary, improvements in body composition may be achieved through dietary energy
restriction combined with resistance training when adequate total protein is consumed in either an
even or skewed distribution pattern.
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3.1

Abstract
Amino acids from meals peak in the plasma at ~180 minutes postprandial. Conversely,

amino acids from rapidly digestible whey protein appear in the plasma within 15 minutes and peak
at 60 minutes postprandial. Therefore, we hypothesized that consuming a 20-g whey protein snack
2 hours after a standard mixed-macronutrient, lower protein breakfast (10 g) would result in peak
and composite postprandial plasma essential amino acid (EAA) responses that were not different
from consuming a 30-g protein breakfast alone. Using a randomized, crossover design, 12 subjects
(6 men, 6 women; age: 29 ± 1 y; BMI: 26.0 ± 1.0 kg/m2; mean ± SE) completed three 330-minute
trials in which they consumed breakfasts containing (i) 10 g of protein (10-PRO, control), (ii) 30
g of protein (30-PRO), and (iii) 10 g of protein followed by 20 g of whey protein isolate 120
minutes later (10/20-PRO). For both 30-PRO and 10/20-PRO, EAA peaked 180 minutes after
breakfast, with greater peak concentrations for 10/20-PRO than 30-PRO (Tukey adjusted, P
< .0001). Essential amino acid positive incremental areas under the curve (iAUCpos) over 300
minutes were not different between 30-PRO and 10/20-PRO. Consuming a rapidly digested whey
protein snack 2 hours after a slowly digested, lower protein breakfast resulted in a greater peak
plasma EAA concentration but comparable plasma EAA availability than consuming a single
higher protein breakfast.

3.2

Introduction
A postprandial increase in plasma essential amino acid concentration (EAA) is required to

initiate and drive skeletal muscle protein synthesis [1-3]. According to Nation Health and Nutrition
Examination Survey data, adults in the United States consume (on average) about 10 g of dietary
protein at breakfast [4,5]. However, ~30 g of high quality protein is needed to maximize the muscle
protein synthesis response [6]. Consuming a higher protein breakfast meal may promote greater
daily muscle protein synthesis rates [7,8], which may better preserve or improve changes in lean
body mass [9-12]. However, practical limitations that impede altering breakfast patterns include
convenience [13,14], appetite/satiety [15-18], and culture [19]. Alternative dietary strategies that
improve composite plasma EAA availability, comparable to consuming a single higher protein
breakfast, are warranted.
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Whey protein isolate is a high-quality, complete protein that contains a high proportion of
leucine [20]. Due to its matrix, whey protein is readily digested and absorbed, appearing in the
plasma within 15 minutes and peaking in concentration approximately 60 minutes following
ingestion [21-28]. Conversely, amino acids from a typical mixed-nutrient meal containing whole,
intact plant or animal-based proteins, peak in the plasma approximately 180 minutes post ingestion
[29-31]. The dissimilar absorption rates suggest that consumption of a moderate amount of rapidly
digestible whey protein isolate supplement during the postprandial period could augment amino
acid responses from a low-protein meal.
Therefore, the primary research objective of this randomized, crossover, acute feeding
study was to compare the plasma EAA concentrations after consuming a lower protein breakfast,
a higher protein breakfast, and a low protein breakfast followed by a whey protein supplement 120
minutes later. To accomplish this objective, postprandial plasma amino acid profiles were assessed
during the fasting (−30 and 0 minutes) and postprandial states (30, 60, 120, 150, 180, 240, and 300
minutes) in overweight adults. We hypothesized that consuming a 20-g whey protein snack 2 hours
after a 10-g low-protein breakfast would result in peak and composite postprandial plasma amino
acid responses that were comparable to consuming a single 30-g higher protein breakfast.

3.3

Methods and materials

3.3.1 Subjects
Twelve subjects (6 women, 6 men; African-American: 1; Asian/Pacific Islander: 2;
Caucasian: 9; age: 29 ± 1 y; BMI: 26.0 ± 1.0 kg/m2; mean ± SE) recruited from the Greater
Lafayette, IN community provided written consent for participation in this study and completed
all study procedures. Study inclusion criteria were: age 25–39 y; BMI: 22–37 kg/m2; weight stable
(± 4.5 kg for the previous 3 months); not currently (and within the past 6 months) following an
exercise regimen; not acutely ill; non-smoking; not diabetic; women not pregnant or planning
pregnancy in the next 2 months; willing to limit purposeful physical exercise for 48 h prior to each
testing day; willing and able to consume study foods and beverages and travel to testing facilities.
Subjects were monetarily compensated for their participation in the study. The study protocol and
all study documents were approved for use by the Purdue University Biomedical Institutional
Review Board. This study is registered at clinicaltrials.gov as NCT02506218.
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3.3.2 Experimental design
This randomized crossover study included three 330-minute testing days each separated by
a minimum of one week (Fig 3.1). Subjects were randomized (using an online randomization plan
generator; http://www.randomization.com/) to consume a low-protein breakfast (10-PRO), highprotein breakfast (30-PRO), and low-protein breakfast followed by a whey protein isolate
supplement 120 minutes after breakfast (10/20-PRO). Randomization and subject allocation was
performed by a clinical laboratory manager who did not participate in data analysis or
interpretation.

Responded to advertising: 53

Completed clinical screening: 13

Randomized to trials: 12

≥7d
Testing day
1

≥7d

Washout

Testing day
2

Washout

Trial

Breakfast protein
intake

Whey protein
supplement

10-PRO
30-PRO
10/20-PRO

10 g protein
30 g protein
10 g protein

0g
0g
20 g

Time (min) -30

0

30

60

120

150

180

Testing day
3

240

300

Blood draw

Subjects completed: 12

Figure 3.1 Subject recruitment flow diagram and experimental protocol.
10-PRO, 10 g protein breakfast; 30-PRO, 30 g protein breakfast; 10/20-PRO, 10 g protein breakfast followed by a
20 g whey protein isolate supplement two hours later.
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Before and between testing days, subjects were instructed to consume their habitual diets
and maintain their customary levels of physical activity. The day before testing, subjects
consumed a controlled, energy sufficient diet (3 meals and 2 snacks) that provided 27% of
energy as fat, 18% of energy as protein, and 55% of energy as carbohydrate. Each subject's total
energy requirement was estimated using sex-specific equations for overweight or obese adults
with a low activity level (physical activity coefficients; male = 1.12; female = 1.16) [32].
Subjects were also counseled to avoid all food and beverages except water during the 12-h
period prior to testing.
On each testing day, subjects reported to the testing facilities in a fasted state. Fasting
plasma and serum samples were drawn from the antecubital vein 30 minutes before (−30 minutes)
and immediately before (0 minutes) breakfast consumption (consumed within 15 minutes).
Additional postprandial plasma and serum samples were drawn at 30, 60, 120, 150, 180, 240, and
300 minutes from the start of the breakfast meal (Fig. 1). The total blood volume sampled over the
entire study period (3 trials) was approximately 200 mL.
3.3.3 Trial diets
All menus were developed so that the total energy consumed during each testing day was
450 kcal (ProNutra, Version 3.3, Viocare, Inc, Princeton, NJ, USA) (Table 3.1). The 3 trials were
characterized by the quantity and timing of the dietary protein consumed: 10-PRO consisted of a
breakfast meal containing 10 g of dietary protein; 30-PRO consisted of a breakfast meal containing
30 g of dietary protein; 10/20-PRO consisted of a breakfast meal containing 10 g of dietary protein
and 120 minutes later a whey protein supplement containing an additional 20 g of whey protein
isolate (Bipro; 80 g protein, 4 g carbohydrates, 2 g fat per 100 g; Agropur Foods, Eden Prairie,
MN, USA), dissolved in 300 mL of water (total dietary protein for 10/20-PRO = 30 g; breakfast
(10 g) + whey protein supplement (20 g)).

Table 3.1 Study diet composition1
Food items
English muffin

Energy
(kcal)
129

10-PRO
CHO
Fat (g)
(g)
1
25

Protein
(g)
5

Energy
(kcal)
129

30-PRO
CHO
Fat (g)
(g)
1
25

Protein
(g)
5

Energy
(kcal)
129

10/20-PRO
CHO
Fat (g)
(g)
1
25

Protein
(g)
5

Margarine

58

6.5

0

0

22

2.5

0

0

39

4.5

0

0

Ham

32

1.5

0

4

129

5

1

18

32

1.5

0

4

Egg whites

3

0

0

1

30

0

0.5

7

3

0

0

1

Grapes

34

0

9

0

27

0

7.5

0

34

0

9

0

Grape juice

72

0

19

0

72

0

19

0

72

0

19

0

Vegetable oil

120

13.5

0

0

40

4.5

0

0

40

4.5

0

0

Whey protein

0

0

0

0

0

0

0

0

100*

0.5

1

20

448

22.5

53

10

449

13

53

30

449

12

54

30

Totals
1

Values are from Nutrition Data System for Research software (NDSR 2012, Nutrition Coordinating Center, University of Minnesota); 10-PRO, 10 g protein
breakfast; 30-PRO, 30 g protein breakfast; 10/20-PRO-10 g protein breakfast followed by 20 g whey protein isolate consumed 120 min after; CHO, carbohydrate.
*Whey protein isolate consumed 120 min after 10 g protein breakfast meal.

61

62

3.3.4 Sample collections and analyses
Single samples of each trial meal were blended into fine homogenates and dehydrated. The
dried samples were individually packaged, sealed, and sent to a commercial analytical laboratory
(Agricultural Experiment Station Chemical Laboratories, University of Missouri-Columbus) for
amino acid analysis [33]. Amino acid profiles for each of the trial diets and whey protein isolate
are displayed in Table 3.2.
Plasma and serum samples were collected at the specified time points, processed, and
aliquoted into cryovials for storage at −80°C as previously described [31]. Samples were thawed
for insulin and glucose analyses or sent out frozen for amino acid analysis. Plasma amino acid
concentrations were determined using cation-exchange chromatography coupled with post-column
ninhydrin derivatization and quantitation [34]. Twenty amino acids were reported (plasma total
amino acids (TAA): sum of Ala, Arg, Apn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe,
Pro, Ser, Thr, Trp, Tyr, and Val). Serum glucose was analyzed by photometric assay (COBAS
Integra 400 Analyzer; Roche Diagnostic Systems, Indianapolis, IN, USA). Serum insulin was
analyzed using Electrochemiluminescence immunoassay (Elecsys 2010 Analyzer; Roche
Diagnostic Systems, Indianapolis, IN, USA).

Table 3.2 Amino acid composition of each trial diet
10/20-PRO10/20-PRO-Whey
Amino Acid1
10-PRO
30-PRO
breakfast
protein
10/20-PRO
Alanine
0.45
1.69
0.45
1.10
1.55
Arginine
0.52
1.80
0.53
0.55
1.08
Aspartic Acid
0.67
2.69
0.67
2.48
3.16
Cysteine
0.15
0.40
0.15
0.61
0.75
Glutamic Acid
2.01
5.03
2.08
3.61
5.69
Glycine
0.41
1.34
0.40
0.38
0.78
Proline
0.75
1.39
0.68
0.95
1.63
Serine
0.36
1.20
0.37
0.74
1.12
Tyrosine
0.26
0.99
0.25
0.72
0.97
Histidine
0.31
1.07
0.30
0.43
0.73
Tryptophan
0.10
0.39
0.11
0.47
0.58
Threonine
0.35
1.30
0.35
1.04
1.39
Methionine
0.20
0.74
0.20
0.51
0.70
Phenylalanine
0.42
1.35
0.42
0.77
1.20
Lysine
0.55
2.31
0.54
2.24
2.79
Isoleucine
0.40
1.46
0.41
1.24
1.65
Valine
0.47
1.70
0.47
1.18
1.65
Leucine
0.71
2.45
0.71
2.76
3.48
Total
9.1
29.3
9.1
21.8
30.9
1
Grams of amino acid in each trial diet. Values were derived from cation-exchange chromatography coupled with post-column
ninhydrin derivatization and quantitation; 10-PRO, 10 g protein breakfast; 30-PRO, 30 g protein breakfast; 10/20-PRObreakfast, 10 g protein breakfast; 10/20-PRO-Whey protein, 20 g whey protein supplement; 10/20-PRO-10 g protein breakfast
followed by 20 g whey protein isolate consumed 120 min after;

63

64

3.3.5 Statistical analyses
Analyses were completed using data from the 12 subjects who completed all 3 testing days.
Baseline characteristics are reported as means ± SE and glucose, insulin, and amino acids are
presented as least-squares means ± SE. Plasma amino acids, serum glucose, and serum insulin
concentrations were statistically analyzed using a doubly repeated-measures analysis of variance
to compare 3 experimental trials and 9 sampling time points. Trial least-squares means at each
time point were compared using the difference of least-squares means. Positive incremental areas
under the curve (iAUCpos) were calculated using the trapezoidal rule with the average of the −30
and 0 time points used as the baseline [35]. A repeated-measures analysis of variance was used to
compare the iAUCpos among trials. Statistical significance was assigned with a Tukey adjusted P
< .05. All statistical analyses were performed using SAS 9.3 (SAS Institute Inc, Cary, NC, USA).

3.4

Results

3.4.1 Subject characteristics
Subject characteristics are reported in section 3.3.1 Subjects. All fasting measures for
glucose, insulin, and amino acid concentrations (TAA, EAA, BCAA, and leucine) were not
different among trials. There were no adverse side effects during any of the trials reportable to the
Purdue University Institutional Review Board.
3.4.2 Serum glucose and insulin
Postprandial serum glucose and insulin concentrations at each time point were not different
among trials (Table 3.3). Correspondingly, iAUCpos over 300 minutes were also not different
among trials (Table 3.3).
3.4.3 Plasma amino acids
There were significant main effects of time and trial, and trial-by-time for TAA, EAA,
BCAA, and leucine concentrations (P < .001). Specifically, 10-PRO postprandial EAA
concentrations did not increase above the fasting concentration (Fig. 3.2A). For both 30-PRO and
10/20-PRO, EAA peaked 180 minutes after breakfast, with greater peak concentrations for 10/20PRO than 30-PRO (P < .0001). EAA iAUCpos over 300 minutes was greater for 30-PRO and
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10/20-PRO than for 10-PRO (P < .0001) (Fig. 3.2B). iAUCpos for EAA were not different between
30-PRO and 10/20-PRO (Fig. 3.2B). The responses and statistical results (i.e. comparisons among
trials at each time point) for the plasma TAA, BCAA, and leucine (Fig. 3.2B and C) concentrations
were comparable to the plasma EAA concentrations (Table 3.3).
B

300
250

‡
¥

†

200

†

150
100
50
0

Breakfast
-30

C

30

150

Leucine (μg/mL)

¥

40

¥

†

20
10
Breakfast
30

Whey protein*
90

150

10/20-PRO

5000
a

10-PRO
D

‡

-30

30-PRO

10000

270

60

30

b

0
210

‡

50

b
15000

Whey protein*
90

70

0

20000

‡

10-PRO
30-PRO
10/20-PRO

Essential amino acid iAUCpos
(μg/mL/h)

Essential Amino Acids (μg/mL)

350

6000

Leucine iAUCpos (μg/mL/h)

A

c
4500
b
3000
1500

a

0
210

270

10-PRO

30-PRO

10/20-PRO

Time (min)

Figure 3.2 Changes in plasma amino acid concentrations
Plasma essential amino acid (A) and leucine (C) concentrations in the fasted (-30 and 0 min) and postprandial (30300 min) periods after ingestion of a 10 g protein breakfast (10-PRO), 30 g protein breakfast (30-PRO), and a 10 g
protein breakfast followed by a 20 g whey protein isolate supplement two hours later (10/20-PRO). *Only consumed
in 10/20-PRO. †, 30-PRO significantly different from 10-PRO and 10/20-PRO (Tukey adjusted, P < 0.05). ‡,
Significantly different from each other (Tukey adjusted, P < 0.05). ¥, 30-PRO and 10/20-PRO significantly different
from 10-PRO (Tukey adjusted, P < 0.05). Positive incremental areas under the curve (iAUCpos) of plasma essential
amino acids (B) and leucine (D). Different letters indicate a significant difference (Tukey adjusted, P < 0.05). All
values are least-squares means ± SE; n = 12 (6 males, 6 females).

Table 3.3 Fasting and postprandial plasma amino acid, glucose, and insulin concentrations and areas under the curve
-30

0

30

60

Time (min)
120
μg/mL1

150

180

240

300

iAUCpos
μg/mL*300 min2

347 ± 27a,3
327 ± 27a
317 ± 27a

333 ± 27a
319 ± 27a
314 ± 27a

360 ± 27a
342 ± 27a
320 ± 27a

346 ± 27a
372 ± 27a
324 ± 27a

358 ± 27a
422 ± 27b
354 ± 27a

360 ± 27a
445 ± 27b
497 ± 27b

337 ± 27a
454 ± 27b
567 ± 27c

327 ± 27a
440 ± 27b
411 ± 27b

311 ± 27a
388 ± 27b
323 ± 27a

4769 ± 1604a
25163 ± 1604b
28288 ± 1604b

147 ± 6a
138 ± 6a
135 ± 7a

139 ± 6a
135 ± 6a
134 ± 7a

145 ± 6a
142 ± 6a
132 ± 7a

135 ± 6a
154 ± 6a
129 ± 7a

137 ± 6a
183 ± 6b
144 ± 7a

141 ± 6a
202 ± 6b
251 ± 7c

134 ± 6a
211 ± 6b
302 ± 7c

130 ± 6a
211 ± 6b
203 ± 7b

124 ± 6a
181 ± 6b
148 ± 7a

1009 ± 1033a
15307 ±1033b
15263 ± 1033b

61 ± 4a
57 ± 4a
55 ± 4a

57 ± 4a
55 ± 4a
55 ± 4a

59 ± 4a
59 ± 4a
53 ± 4a

53 ± 4a
62 ± 4a
50 ± 4a

53 ± 4a
74 ± 4b
57 ± 4a

55 ± 4a
84 ± 4b
114 ± 4c

52 ± 4a
90 ± 4b
146 ± 4c

51 ± 4a
96 ± 4b
97 ± 4b

50 ± 4a
85 ± 4b
69 ± 4b

261 ± 506a
8894± 506b
7139 ± 506b

19 ± 1a
18 ± 1a
17 ± 2a

18 ± 1a
18 ± 1a
17 ± 2a

18 ± 1a
19 ± 1a
16 ± 2a

16 ± 1a
20 ± 1a
15 ± 2a

16 ± 1a
24 ± 1b
18 ± 2a

16 ± 1a
28 ± 1b
46 ± 2c

16 ± 1a
30 ± 1b
63 ± 2c

15 ± 1 a
32 ± 1b
38 ± 2b

15 ± 1a
27 ± 1b
25 ± 2b

93 ± 205a
2425 ± 205b
4548 ± 205c

199 ± 6a
189 ± 6a
182 ± 7a

193 ± 6a
184 ± 6a
180 ± 7a

214 ± 6 9a
200 ± 6a
188 ± 7a

212 ± 6a
219 ± 6a
194 ± 7a

221 ± 6a
240 ± 6a
210 ± 7a

220 ± 6a
243 ± 6a
246 ± 7a

203 ± 6a
244 ± 6b
266 ± 7b

197 ± 6a
231 ± 6b
208 ± 7a,b

187 ± 6a,b
207 ± 6b
175 ± 7a

4344 ± 792a
9433 ± 792b
12997 ± 792b

TAA
10-PRO
30-PRO
10/20-PRO
EAA
10-PRO
30-PRO
10/20-PRO
BCAA
10-PRO
30-PRO
10/20-PRO
Leucine
10-PRO
30-PRO
10/20-PRO
NEAA
10-PRO
30-PRO
10/20-PRO

66

Table 3.3 continued. Fasting and postprandial plasma amino acid, glucose, and insulin concentrations and areas under the curve

Glucose
10-PRO
30-PRO
10/20-PRO

-30

0

30

60

88 ± 3a
91 ± 3a
90 ± 3a

90 ± 3a
92 ± 3a
90 ± 3a

133 ± 3a
130 ± 3a
125 ± 3a

111 ± 3a
115 ± 3a
107 ± 3a

Time (min)
120
mg/dL
90 ± 3a
89 ± 3a
92 ± 3a
μIU/mL

150

180

240

300

iAUCpos
mg/dL*300 min

86 ± 3a
89 ± 3a
80 ± 3a

84 ± 3a
89 ± 3a
76 ± 3a

86 ± 3a
89 ± 3a
86 ± 3a

87 ± 3a
90 ± 3a
86 ± 3a

2765 ± 368a
2830 ± 368a
2155 ± 368a
μIU/mL*300 min

Insulin
10-PRO
9.7 ± 5a
8.5 ± 5a
62.5 ± 5a
54.2 ± 5a
32.5 ± 5a
23.3 ± 5a
16.1 ± 5a
9.3 ± 5a
7.6 ± 5a
5392 ± 1059a
30-PRO
10.0 ± 5a
9.0 ± 5a
56.4 ± 5a
63.5 ± 5a
30.4 ± 5a
25.5 ± 5a
18.5 ± 5a
14.5 ± 5a
9.3 ± 5a
6446 ± 1059a
a
a
a
a
a
a
a
a
a
10/20-PRO
11.6 ± 6
10.3 ± 6
57.8 ± 6
51.5 ± 6
39.5 ± 6
45.6 ± 6
31.4 ± 6
13.7 ± 6
9.2 ± 6
6879 ± 1059a
1
Values are least-squares means ± SE; n =12. Plasma amino acid glucose, and insulin concentrations were measured over 330 min. Data were analyzed using a doubly
repeated measures ANOVA (proc mixed; SAS version 9.3). Differences in means were determined using a Tukey post hoc test. Trial-by-time interactions for TAAs,
EAAs, BCAAs, leucine, and NEAAs were all significant, Tukey adjusted P < 0.001. TAA, total amino acids (sum of Ala, Arg, Apn, Asp, Cys, Gln, Glu, Gly, His, Ile,
Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, and Val); EAA, essential amino acids (sum of His, Ile, Leu, Lys, Met, Phe, Thr, Trp, and Val); BCAA, branched-chain
amino acids (sum of Leu, Ile, and Val); NEAA, non-essential amino acids (sum of Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, Pro, Ser, and Tyr); iAUCpos, positive
incremental area under the curve; 10-PRO, 10 g protein breakfast; 30-PRO, 30 g protein breakfast; 10/20-PRO, 10 g protein breakfast followed by 20 g whey protein
isolate consumed 120 min after.
2
The average of the -30 and 0 time points were used as baseline.
3
Least-squares means or means within time point or iAUCpos with different superscript letter are significantly different from each other, Tukey adjusted P < 0.05; n =
12 (6 males, 6 females).

67

68

3.5

Discussion
Our goal was to leverage the rapid digestion/absorption kinetics of whey protein to bolster

the plasma EAA profile achieved by consuming a traditional lower protein, mixed macronutrient
breakfast. In accordance with our hypothesis, we observed that consuming 20 g of whey protein
isolate after a 10 g-protein breakfast (10/20-PRO) resulted in comparable composite plasma EAA
availability compared to consuming a single, 30-g protein breakfast (30-PRO). However, contrary
to our hypothesis, the peak plasma EAA concentration was significantly greater for 10/20-PRO
than 30-PRO.
Adults in most developed countries typically consume a carbohydrate-rich breakfast,
containing a relatively low quantity of dietary protein (~10 g) [4,36]. This is followed by a
midmorning snack that is also high in carbohydrate and fat and low in protein [4]. However, results
from multiple acute studies showed that consuming 10 g of protein as whole foods [37] or isolated
protein [1,38] may not provide sufficient substrate to support increases in peripheral skeletal
muscle protein synthesis above basal rates. The breakfast meal in our 10-PRO group contained 10
g of protein from mixed, whole food protein sources (~50% from animal sources, 50% from plant
sources). This meal was designed to be representative of a typical breakfast meal consumed in
developed countries [4,5]. Compared to most isolated protein sources, protein from whole foods
is associated with decreased digestion and absorption rates [39]. This may have special relevance
given that a rapid increase in plasma and intracellular EAA is thought to stimulate muscle protein
synthesis [40-42].
After a standard mixed-nutrient breakfast containing 10 g of protein, we expected to see a
modest rise in plasma EAA concentrations, peaking after 3 hours [31]; however, following 10PRO, we did not detect any apparent increase in plasma EAA availability. These data support
results from acute studies demonstrating that 10 g of dietary protein, particularly from mixed
sources, may have minimal impact on muscle protein synthesis [1,37,38].
Muscle protein synthesis has a saturable dose–response relation with protein quantity [13,43]; increasing the protein dose increases amino acid availability, leading to greater rates of
muscle protein synthesis [1,3,6,37,38]. We observed greater peak and composite plasma EAA
availability in 30-PRO and 10/20-PRO than 10-PRO. For adults who typically consume a lower
protein breakfast, an alternative to consuming a higher protein breakfast may be to leverage the
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mid-morning snack to augment a “protein-insufficient” breakfast meal. While protein's effects on
muscle protein synthesis are frequently considered, the interactive effects of consuming protein at
2 different eating occasions are largely unappreciated and undocumented. Whey protein is rapidly
digested [21] while amino acids from whole food, mixed-nutrient meals are digested more slowly
[29,30,44]. We demonstrated here that consuming a moderate amount of rapidly digestible whey
protein isolate (20 g) 2 hours after a lower protein breakfast (10 g) increased composite plasma
EAA availability over a 300 minute postprandial period. Importantly, the composite plasma EAA
availability of 10/20-PRO was not different to 30-PRO; suggesting that consuming whey protein
2 hours after a lower protein meal could restore plasma EAA availability comparable to consuming
a single higher protein breakfast meal.
Another possibility is that 10/20-PRO may be superior to 30-PRO in stimulating muscle
protein synthesis regardless of comparable composite plasma EAA availability. The 10/20-PRO
achieved a greater peak plasma EAA concentration than 30-PRO at 180 minutes. Previous research
showed that muscle protein synthesis was greater when plasma amino acid concentrations were
greater although composite availability was the same [41]. Leucine in particular may be a potent
stimulator of muscle protein synthesis [45,46]. Leucine composite and peak availability were
greater in 10/20-PRO than 30-PRO. This may result from the rapid digestion/absorption kinetics
of whey protein coupled with 10/20-PRO containing ~40% more leucine than 30-PRO. Regarding
muscle protein synthesis, our results suggest that consuming a whey protein supplement 2 hours
after a lower protein breakfast would be at least comparable to consuming a single higher protein
breakfast (EAA iAUCpos) or even superior (peak concentration).
A meaningful limitation of this study is that assessing plasma amino acid availability is a
crude and indirect method of estimating anabolic potential. Without directly assessing muscle
protein synthesis, we can only speculate that the changes in plasma amino acid concentrations are
meaningful. Future research that directly measures muscle protein synthesis is required before this
dietary intake approach is recommended and practiced. Additionally, 12 subjects is a modest
sample size and care should be exercised when interpreting these data and extrapolating the results
to the general public.
In conclusion, consuming a moderate (20 g) serving of a whey protein isolate supplement
2 hours after a lower protein, whole foods breakfast (10 g) may restore or improve the anabolic
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potential of breakfast in individuals unable or unwilling to consume a single, higher protein
breakfast meal.
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4.1

Abstract
Context: The impact of timing the consumption of protein supplements in relation to

meals on resistance training-induced changes in body composition has not been systematically
evaluated. Objective: This systematic review assessed the effect of consuming protein
supplements with versus between meals on changes in body composition in adults who
concurrently initiated resistance training. Data Sources: PubMed, Scopus, Cochrane, and
CINAHL were searched using the keywords “dietary protein,” “body composition,” and “lean
mass.” Study Selection and Data Extraction: Two researchers independently screened 2077
abstracts and extracted 264 articles. Data Synthesis: Thirty-four randomized controlled trials
with 59 individual groups met the inclusion criteria. Conclusions: Consuming protein
supplements with meals versus between meals may effectively reduce fat mass, but does not
influence resistance training-induced improvements in lean mass.
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4.2

Introduction
It is well established that consuming dietary protein proximate to resistance-type exercise

sessions promotes a positive net protein balance during post-exercise recovery.(112, 155, 160, 164)
Two meta-analyses demonstrated that consuming protein supplements concurrent with prolonged
resistance exercise training increased lean mass compared to a non-protein supplement
control.(217, 241) These reviews did not consider the timing of protein supplementation with
respect to meals. The impact of consuming protein supplements with versus between meals on
resistance training-induced changes on body composition has not been reviewed.
Protein supplements are available in ready-to-drink, powdered, and solid form and are
marketed to augment contradictory outcomes such as weight gain, weight loss, and weight
management. However, for each outcome, the promoted timing of protein intake varies. Protein
supplements designed to augment weight gain or support weight stability are promoted for
consumption between meals.(242-245) For weight loss, protein supplements are often
recommended for ingestion either with a meal or as a meal replacement.(246, 247) There are
scientific rationales that support consuming a protein supplement either with or between meals to
differentially influence body composition responses. Consuming a protein supplement between
meals may decrease compensatory eating behaviors, thereby increasing energy intakes and body
weight.(248) Conversely, consuming a protein supplement twice daily with meals lead to complete
energetic compensation in adults who performed resistance training, although body composition
was not affected.(249) Consequently, the timing of protein supplementation may be of particular
importance depending on the desired body weight and body composition outcome. The aim of this
systematic review of literature was to investigate whether the existing research studies support
consuming protein supplements between meals versus with meals to differentially change body
composition in adults who initiate resistance training regimens.

4.3

Methods
The current systematic review followed the PRISMA (Preferred Reporting Items for

Systematic Reviews and MetaAnalyses) guidelines. The description of the PICOS (population,
intervention, comparison, outcome, and study design) criteria used to define the research question
is presented in Table 4.1.
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Table 4.1 PICOS criteria
Parameter

Description

Population

Apparently healthy adults, group mean age ≥19 y

Intervention

Groups that consumed protein supplements between meals

Comparison control

Groups that consumed protein supplements with meals

Outcome

Changes in lean mass

Study design

Studies ≥ 6 weeks in length
What is the effect of consuming a protein supplement with versus between meals on
changes in body composition in resistance training adults?

Research question

4.3.1 Data sources
A systematic search of the literature was conducted in April 2016 using PubMed, Cochrane
Reviews, Scopus, and CINAHL databases and is current to May 2017. Search terms, keywords,
and phrases were selected to include appropriate articles on protein supplementation, lean mass,
and resistance training (Appendix B. Table 1).
4.3.2 Inclusion criteria
Inclusion criteria were as follows: randomized controlled trial with parallel design;
intervention duration ≥ 6 weeks; group mean age ≥ 19 years; male or female participants; pre- or
post-menopausal females; apparently healthy humans with no intentional/prescribed diet-induced
energy restriction or surplus; concurrent resistance training with or without aerobic training;
prescribed a protein supplement while indicating the timing of ingestion; use of an acceptable
method of body composition assessment; and English language publication. Protein supplements
(whey, casein, soy, bovine colostrum and rice) were acceptable if they were isolates, concentrates,
or hydrolysates consumed alone or in combination with other nutrients (creatine, amino acids, and
carbohydrate) and protein sources. Dual-energy x-ray absorptiometry, air-displacement
plethysmography, and hydrostatic weighing were deemed acceptable methods for detecting
changes in lean mass based on their high reliability and validity.(58, 250-253) Total body
potassium and doubly labeled water were also acceptable; however, none of the vetted articles
used these methods. Articles that used skin folds and bioelectrical impedance were excluded due
to unreliable estimations of lean mass.(254, 255)
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4.3.3 Article selection and data extraction
Collectively, database searches yielded 2074 articles (PubMed: 1207; Cochrane: 243;
Scopus: 157; CINAHL: 468). After screening abstracts, 264 articles were independently read and
reviewed by the primary reviewer (J.L.H) and the secondary reviewer (R.E.B) including three
other article identified from other sources. A total of 230 were excluded for the following reasons:
full text was not accessible to the reviewers, article did not report on protein supplement-related
research; subject group mean age was < 19 y; subjects were in energy restriction; lean mass was
not reported or was reported only graphically and numerical data were not accessible; researchers
used an unacceptable method of body composition assessment; or subjects were characterized as
having a chronic disease or having severe injury. Four of seven authors contacted for data
responded and provided data included in this systematic review. Thirty-four articles were selected
for inclusion in this systematic review (Figure 4.1).(229, 231, 232, 249, 256-285)

Figure 4.1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart
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Primary (J.L.H.) and secondary (R.E.B.) reviewers independently extracted the following
information from the selected articles using an electronic form: first author’s last name; publication
year; sample sizes of each intervention group; subject sex; group mean age; intervention duration;
prescribed protein supplement timing protein source; resistance training frequency; method of
body composition assessment; and pre- and post-intervention and net changes in body mass, lean
mass, and fat mass. Incongruous information extracted between reviewers was reexamined and
discussed until concurrence was achieved.
Twenty-nine articles included in this review measured body composition using dual energy
x-ray absorptiometry. Two more articles utilized air displacement plethysmography and three used
hydrostatic weighing to measure body composition. There were some discrepancies in how lean
mass was reported, with 21 articles using the term lean mass, 6 articles using lean tissue mass, 6
articles using fat-free mass, and 1 article using bone-free fat-free mass. For this review, these terms
were considered synonymous and lean mass is used consistently. Articles that included bone
mineral content within lean mass were included in the analyses because bone mineral content only
accounts for approximately 5% of total lean mass(286); moreover, bone turnover (remodeling) is
slow, requiring a minimum of 4 to 6 months.(287)
4.3.4 Critical appraisal
The risks of selection, performance, and detection biases were evaluated from selected
articles using a modified Cochrane tool (Appendix B. Table 2).(288) Details of methods for
assessment of dietary control are also included in Appendix B. Table 2.
4.3.5 Calculations
With meal ingestion (PRO-WITH; n=9 articles and 16 groups(229, 231, 232, 249, 256260)) is defined as a dietary protein-rich supplement consumed immediately after a meal (n=4),
with a meal (n=9), or as a high-protein meal replacement (n=3) (Appendix B. Table 3). Between
meals ingestion (PRO-BET; n=25 articles and 43 groups(261-285)) is defined as consuming a
dietary protein supplement predominantly either proximate to resistance training (n= 31) or during
a generic time period (i.e. before bed (n=1), before breakfast and before bed (n=1), between
breakfast and lunch and before bed (n=1), mid-morning and before bed (n=3), mid-morning and
evening (n=2), morning and evening (n=1), upon waking and before bed (n=3)) (Appendix B.
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Table 3). Articles that included groups whose prescribed supplement timing fit into both the “with”
and “between” categories were classified based on the predominant timing of supplementation
(n=3 articles and 6 groups(231, 258, 260)). For example, a group consuming a dietary protein
supplement with breakfast on non RT days and a dietary protein supplement post RT would be
placed in the PRO-WITH category if they trained ≤ 3 d/wk.
The number of articles that reported changes in body mass, lean mass, and fat mass varied
since some articles did not report results for all parameters. Some articles also did not report
changes from baseline. For these articles, the absolute change and percent change were calculated
as the difference between pre- and post-intervention. The results from each group are presented
qualitatively as categorical variables that are either increasing or decreasing from baseline.
A modified form of a previously published coding system to classify strength of evidence
of associations with physical activity in children and adolescents was used to summarize the effect
of consuming protein supplements with versus between meals on body mass, lean mass, and fat
mass (Table 4.2).(289) The coding system was used to provide discreet cutoffs to indicate whether
the totality of the research included in the current review consistently or inconsistently affected
the outcomes of interest. If 34-66% of groups experienced a change from baseline, the result was
categorized as an inconsistent effect (designated as ‘↔’). When 67-100% of the groups
experienced a change from baseline, the result was categorized as either a consistent positive (↑,
increase from baseline) or negative (↓, decrease from baseline) effect. By default, if 67-100% of
groups reported a change from baseline for a specific outcome, 0-33% of groups reported a change
in the opposite direction. Similarly, if a result was categorized as having an inconsistent effect, by
default, the effect was inconsistent in both the positive and negative direction. Therefore, only the
inconsistent and consistent results are reported.
Table 4.2 Rules for classifying outcomes regarding strength of evidence 1
Percent of groups
supporting outcome
34-66

Summary code
Meaning of code
↔
Inconsistent effect
Consistent positive effect
↑
67-100
Consistent negative effect
↓
1
Codes represent summary of effect. Inconsistent effect (↔): 34-66% of groups reported either
an increase or decrease from baseline; consistent positive (increase) (↑) or negative (decrease)
(↓) effect: 67-100% of groups reported a change in that direction from baseline.
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4.4

Results

4.4.1 Study features and subject characteristics
Thirty-four articles including 59 intervention groups met all inclusion criteria. Forty-three
of the groups were classified as PRO-BET and 16 were classified as PRO-WITH. This resulted in
a total of 608 subjects included in the PRO-BET category (age: <50 y: n = 30 groups; >50 y: n =
13 groups; mean: 55 y; median: 25 y; range: 19-74 y) and 373 subjects in the PRO-WITH category
(age: <50 y: n = 3 groups; >50 y: n = 13 groups; mean: 55 y; median: 25 y; range: 23-81 y).
Twenty-seven groups in the PRO-BET category were <12 wk in duration and 16 were ≥12-16 wk
in duration. All 16 of the PRO-WITH groups were ≥12-36 wk in duration with 7 being ≥12-16 wk
long.
4.4.2 Quality of selected articles
Six articles were deemed at low risk of selection bias, since they provided specified
methods of randomization and/or allocation concealment in the original articles, while the other
selected articles did not clearly report the randomization and allocation concealment methods
(Appendix B. Table 2). Twenty-seven of the 34 articles included details on whether participants
and investigator(s) were blinded during the intervention or until data collection was completed.
Thirty-one articles indicated that the protein supplements used in the article were provided to the
subjects.
4.4.3 Results of systematically searched assessment
A quantitative meta-analysis could not be performed because our systematic search of
literature did not identify any randomized controlled trial directly comparing the effects of
consuming protein supplements with versus between meals on body composition changes with
resistance training. Qualitatively, consuming protein supplements between meals had a consistent
effect on increasing body mass (72% of groups) whereas consuming protein supplements with
meals had an inconsistent effect (56%) (Figure 4.2). When protein supplements were consumed
with and between meals, there was a consistent positive effect on lean mass (90% of PRO-BET
and 94% of PRO-WITH). Consuming protein supplements between meals had an inconsistent
effect on fat mass (41%) whereas consuming protein supplements with meals had a consistent
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negative effect on fat mass (87%). In regards to changes in lean mass to fat mass ratio, consuming
protein supplements between and with meals had a consistent positive effect on the ratio (84% of
PRO-BET and 100% of PRO-WITH).
A secondary quasi-sensitivity analysis was done using results from groups whose
interventions were ≥12-16 wk in duration to better control for any potential temporal effects of the
intervention on the outcomes (Appendix B. Table 4). The results are comparable to the analyses
including all groups. Consuming protein supplements between meals (n=16 groups) had consistent
positive effects on body mass, lean mass, and lean to fat mass ratio; there was an inconsistent effect
on fat mass. Consuming protein supplements with meals (n=7 groups) had a consistent negative
effect on body mass and fat mass and a consistent positive effect on lean mass and lean to fat mass
ratio.
Further quasi-sensitivity analyses were done with young adults (mean group age 19-50 y);
older adults (mean group age > 50 y); groups consuming protein supplement doses estimated to
achieve maximal muscle protein synthesis (≥0.24 and 0.40 g/kg/d in younger and middle aged
adults and older adults, respectively); matching dosing ranges (10-75 g/d); matching total protein
intake ranges (0.9-1.6 g/kg/d); matched dosing and total protein intake ranges; and excluding
studies when a protein supplement also contained creatine (Appendix B. Table 4). Creatine
supplementation was found to increase total body mass and lean mass in older adults concurrently
resistance training in two previous meta-analyses(290, 291) and was assessed for any mediating
effect of the results reported in the current review. The qualitative results from the quasi-sensitivity
analyses are comparable to the original analyses, although this cannot be statistically confirmed.
The directional changes from baseline are reported here and specific magnitudes of changes for
each outcome are in Appendix B. Table 5.

Figure 4.2 Changes in body mass, fat mass, lean mass, and lean to fat mass ratio in groups consuming protein supplements with versus between meals.1
A modified form of a previously published coding system was used to summarize the effects of consuming protein supplements with versus between
meals.(289) 2Represents the percentage of groups that reported either an increase or decrease from baseline. 3Represents the number of groups that reported either
an increase or decrease from baseline out of the total number of groups for each outcome. Abbreviations: ↔, inconsistent effect: 34-66% of groups reported either
an increase or decrease from baseline; ↑, consistent positive effect (increase from baseline): 67-100% of groups reported a change in that direction from baseline;
↓, consistent negative effect (decrease from baseline): 67-100% of groups reported a change in that direction from baseline; PRO-WITH, groups ingesting protein
supplements with meals; PRO-BET, groups ingesting protein supplements between meals.
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4.5

Discussion
The objective of this systematically searched assessment of literature was to assess if

consuming protein supplements with meals versus between meals differentially affected changes
in body composition in adults concurrently performing resistance training. Qualitatively, results
suggest that consuming protein supplements between meals may promote increases in body mass
and consuming protein supplements with meals may promote reductions in fat mass. Consistent
improvements in lean mass and lean to fat mass ratio may be achieved when consuming protein
supplements either between or with meals in combinations with resistance training.
Consuming protein supplements between meals consistently increased body mass whereas
consuming protein supplements with meals had an inconsistent result. One inclusion criterion for
this systematic review was the absence of a controlled diet aimed at regulating energy intake.
Groups were effectively “free-feeding” adults. With this in mind, protein supplements consumed
between meals could be considered a snacking occasion. Although the definition of “snacking” is
not clear, it is generally agreed upon that consuming energy-containing foods or beverages outside
a primary eating occasion (i.e. breakfast, lunch, dinner) is an acceptable designation.(292) In one
two-week long study, mandatory snacking promoted weight gain in free-living adults.(248) This
effect was shown to be exacerbated when the snacks were consumed as beverages,(293, 294) the
predominant form of protein supplement among the groups included in this review. Consuming
protein supplements between meals or “snacking” may also increase eating frequency, which may
promote higher body weight.(295-297) In contrast, consuming protein supplements with meals or
as meal replacements renders them meal components. They may displace some of the energy that
otherwise would have been consumed at that meal time. Results from one randomized controlled
trial showed that when subjects consumed a ~200 kcal whey protein-rich supplement twice daily
(with breakfast and lunch meals) for 36 weeks, they had complete energetic compensation in the
diet and maintained their body weight.(249) Collectively, results from the current systematic
review fit within existing observational and randomized control trial literature demonstrating that
protein supplementation between meals may promote greater increases in body mass than protein
supplementation with meals.
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Consuming protein supplements either between or with meals in combination with
resistance exercise training consistently increased lean mass. This finding suggests that resistance
training is a more potent anabolic stimulus than the timing of protein supplementation in relation
to meals. Consuming protein supplements while concurrently resistance training creates a positive
net protein balance.(112, 155, 160, 164) Two meta-analyses showed that participants who
consumed protein supplements while resistance training had greater lean mass accretion versus
participants consuming a non-protein placebo.(217, 298) Results from the current study support
previous findings that increases in lean mass can be attained through resistance training while
consuming protein supplements.(217, 298)
Consuming protein supplements with meals consistently decreased fat mass, whereas
consuming protein supplements between meals had inconsistent effects on fat mass. Consuming
protein supplements with meals may lead to partial meal replacement that would displace the
energy that otherwise would be consumed. The within-meal effects of protein supplementation are
consistent with previously observations that adults may fully compensate for the additional energy
from protein supplements when they were consumed with meals.(249) The decrease in fat mass
fits within the results from this systematic review showing a consistent increase in lean mass and
inconsistent change in body mass. Since lean mass is consistently increasing, and body mass
change is inconsistent, it would follow that fat mass would decrease.
4.5.1 Strengths and limitations
This review is subject to standard limitations of systematic reviews such as publication bias
and keyword formation that omit publications that would fit within the search parameters.
However, in addition to systematically searching PubMed, CINAHL, Cochrane Reviews, and
Scopus, reviewers independently assessed articles within relevant meta-analyses for inclusion in
this study to mitigate these limitations. Specific limitations to this study include a disproportionate
over-representation of older adults in the PRO-WITH versus the PRO-BET category, variations in
study duration, and differences in supplementation quantity and total protein intake. To address
these potential confounding factors, quasi-sensitivity analyses were conducted to investigate any
potential influence on the outcomes (Appendix B. Tables 4-5). There do not appear to be
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differences in the proportion of groups within each outcome; however, the inability to perform
statistical analyses on the subgroups prohibits conclusive statements about their influence.
This systematic review’s inclusion/exclusion criteria were designed to capture studies that
adequately documented protein supplementation in relation to meals. Incidentally, more PRO-BET
groups consumed protein supplements proximate to resistance training sessions (before or after)
than PRO-WITH groups. Protein supplementation around resistance training has oft been a topic
of interest to supply the skeletal muscle with the necessary precursor amino acids to promote
skeletal muscle growth. However, the influence of protein supplementation timing could not be
adequately reviewed or speculated on here because there may be relevant research not captured
during this review process. Four studies included in this review do test the effect of protein
supplementation timing proximate versus not proximate to resistance training.(264, 266, 271, 274)
Three studies reported that protein supplementation timing did not differentially affect changes in
lean mass(264, 271, 274) while one reported that protein supplementation before and after
resistance training promoted greater gains in lean mass than when the same protein supplement
was consumed in the morning and evening.(266) Supplements containing mixtures of protein and
creatine may be another potential limitation.(290, 291) A quasi-sensitivity analysis excluding
groups that consumed protein supplements with creatine did not alter the reported results.
Collectively, these quasi-sensitivity analyses should be interpreted with caution due to the low
number of groups within each category. There is also the possibility that the effects reported in the
current review may not be specific to protein supplementation but to the energy contents of the
supplements. Further research that includes non-protein supplements is needed.

4.6

Conclusion
The results from this systematic review provides novel information for individuals who

choose to consume a protein supplement as part of their dietary pattern to promote body mass gain
or improved body composition through fat mass reduction. Regardless of protein supplement
timing in relation to meals, lean mass is likely to increase in response to resistance training.
However, consuming protein supplements with meals rather than between meals may be a more
effective dietary strategy to improve resistance training-induced changes in body composition by
reducing fat mass, which may be relevant for adults undergoing purposeful weight loss to improve
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their health status. Conversely, consuming protein supplements between meals may be more
effective at increasing overall body mass.
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CONCLUSIONS AND FUTURE DIRECTIONS

5.1

Research conclusions
See Chapter 2, subsection 2.5 for a detailed discussion of the results from study 1. In brief,

too often results from acute trials, lasting only several hours in duration and often less than one
day, are used to make dietary recommendations for improving health. Perhaps most prominent and
well-known in the public are the acute effects of carbohydrate-rich meals on stimulating insulin
release—an anabolic hormone. Recommendations are frequently made by laymen and health
professionals alike to reduce carbohydrate intake to induce weight loss. The unfortunate
consequence is a focus on dietary macronutrient composition and not around habitual energy
intake. The folly in logic comes with concluding that long-term phenotypic changes could be
predicted with short-term, physiologic assessments. The protein distribution concept may fall prey
to the same illogical ideology.
In theory, higher protein synthesis rates would seem predictive of greater lean mass.
However, this conclusion ignores the other half of the net protein balance model: muscle protein
breakdown. Muscle protein balance is the difference between synthesis and breakdown. Only
when synthesis is greater than breakdown can muscle tissue be accreted. The paucity of literature
comprising the protein distribution concept focused only on muscle protein synthesis, ignoring
breakdown, making it impossible to objectively assess net balance within the same study design.
Regardless, it remains enigmatic whether supposed improvements in net protein balance from
higher protein synthesis rates would predict changes in skeletal muscle mass.
Study 1 (Chapter 2) was designed to assess whether evenly distributing dietary protein
intake from a typically skewed protein distribution would attenuate the loss of lean mass that
usually accompanies consuming an energy-restricted diet even while resistance training. Adults in
both groups reduced their body mass by ~8% while simultaneously increasing their whole body
strength by ~20%. Whole body lean mass and skeletal muscle thigh and calf area were not affected
by protein distribution. We found that improvements in body composition may be achieved
through dietary energy restriction combined with resistance training when adequate total protein
is consumed in either an even or skewed distribution pattern. These data highlight the potential for
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making erroneous claims by extrapolating from short-term studies without evidence from longerterm clinical trials.
Study 2 (Chapter 3) of this document was designed to test whether different dietary sources
with dissimilar digestion and absorption rates could be consumed at separate eating events so as
to appear in circulation simultaneously. The adoption of this dietary pattern would allow a person
to divide their daily protein into smaller, perhaps more manageable portions. Breakfast is a
notoriously low protein-containing meal and its participants find it difficult to change their
ingestive behaviors. In response to this, we designed a study to test whether the anabolic potential
of a higher protein breakfast could be maintained or even improved without altering the typical
lower protein breakfast. We found that consuming a moderate (20 g) serving of a whey protein
isolate supplement two hours after a lower protein, whole foods breakfast (10 g) may restore or
improve the anabolic potential of a breakfast in individuals unable or unwilling to consume a
single, higher protein breakfast meal.
While physiologically interesting, there may be ingestive behavioral ramifications to
including a protein supplement between breakfast and lunch that could impact body weight and
body composition. Limited observational and randomized controlled trial literature provide
evidence of higher meal frequency contributing to excess adiposity. Consuming a protein
supplement between meals may, in effect, increase meal frequency and increase daily energy
intake. Study 3 (Chapter 4) of this document is a systematically searched evaluation of randomized
controlled trials that utilized protein supplements in their study designs and prescribed a resistance
training regimen. Regardless of protein supplement timing in relation to meals, lean mass is likely
to increase in response to resistance training. However, consuming protein supplements with meals
rather that between meals may be a more effective dietary strategy to improve resistance traininginduced changes in body composition by reducing fat mass, which may be relevant for overweight
adults undergoing purposeful weight loss. Conversely, consuming protein supplements between
meals may be more effective at increasing overall body mass.

5.2

Future directions
As can happen with research focused on discerning nuances, Study 1 (Chapter 2) was

underpowered to detect an effect of protein distribution on lean mass changes. This study was the
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first designed to test whether protein distribution influenced weight loss- and resistance traininginduced changes in body composition. Future research should use our findings to appropriately
design their study to account for relatively minor changes in lean mass (~3%) over 16 wk.
Nonetheless, even with inadequate power, consuming a skewed protein distribution trended
(P=0.067) toward greater lean mass attenuation than after consuming an even protein distribution.
It is possible that in the context of a practical dietary pattern, consuming an even distribution based
on the 30-30-30 conception (30 g of protein at breakfast, lunch, and dinner) does not provide
enough protein to maximally stimulate MPS at each meal of the day. Further researchers may need
to design their study to either 1) increase the daily protein quantity or 2) reduce the body mass of
subjects allowed to participate in the study. Either would increase the relative protein quantity,
both daily and per meal. This may “facilitate” maximal MPS stimulation at each meal. In Study 2
(Chapter 3), future research that directly measures MPS should be performed before this dietary
approach is recommended and practiced. Plasma amino acid concentrations are a crude and
indirect method of estimating anabolic potential. Without directly assessing MPS, we can only
speculate that changes in plasma amino acid concentrations are meaningful. Following the stable
isotope studies, research should directly test whether adopting this dietary pattern has statistically
and clinically meaningful effects on skeletal muscle changes. Caution should also be employed to
adequately power these studies because of the nuanced dietary manipulation.
Study 3 (Chapter 4) offers the more promising of future scientific endeavors. Results from
this study indicate that future research should use a randomized controlled trial design to test the
effect of consuming a protein supplement with versus between meals on changes in body mass and
composition. If future research confirms the results from Study 3, a major focus should be on how
we can improve recommendations for consuming energy-rich, protein containing nutritional
supplements, particularly in aging adults. There is a need for more nutritional intervention research
designed to address the decrements in skeletal muscle function and mass observed in aging
populations. Study 3 could be the foundation to address nutrition and muscle related concerns for
older adults.
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Appendix A Table 1. Study design for the EVEN and SKEW groups while consuming an energy-restricted diet and performing resistance training for 16 wk
SKEW* protein distribution with resistance training
Parameter

Pre-intervention
measurements

Post-intervention
measurements

EVEN* protein distribution with resistance training
90 g protein/d; Total energy intake 750 kcal/d below estimated energy needs

Study weeks

0

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

Body weight

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Body composition

X

X

Biochemical analyses

X

X

24-h dietary recalls

X

X

Menu checklist compliance

X

Meal picture compliance
Strength testing
Resistance training compliance

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X
X

X

X

X

X

X

X

X

X

X

X

X
X

X

X

X

X
X

X

X

X

X
X

X

X

X

*EVEN, 30 g of protein consumed at breakfast, lunch, and dinner; SKEW, 10 g of protein consumed at breakfast, 20 g at lunch, and 60 g at dinner
Abbreviations: Body composition: DXA, dual energy X-ray absorptiometry; MRI, magnetic resonance imaging; BMI, height, waist and hip circumference.
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Appendix A Table 2. Dietary protein source quantity in the EVEN and SKEW groups while consuming an energyrestricted diet and performing resistance training for 16 wk 1
Protein source
Pork
Beef
Dairy
Egg
Fish
Non-animal

Protein source quantity
(%/wk)
18
18
18
10
4
30

1

Protein source quantity
(servings/wk)
52
52
143
84
12
—

Values are the prescribed protein source quantities that both groups
consumed.
2

1 serving = 3 oz
1 serving = 8 oz milk, 6 oz yogurt, or 1 oz cheese
4
1 serving = 1 large whole egg
3

Appendix A Table 3. Detailed procedures used for assessing subjects in the EVEN and SKEW groups while consuming an energy-restricted diet and performing
resistance training for 16 wk
Methods
Dietary
compliance

Procedures
Completed menu checklists were collected and new menus distributed at the beginning of each week when the subjects performed the
first of three weekly resistance training sessions. After receiving the checklists, research staff would calculate compliance. Menu
checklist compliance is calculate as the total number of compliant meals out of 294 meals (14 wk). The percent of non-compliant meals
were further categorized by whether the subjects deviated from the menu, under consumed for that meal (missing food item), or did not
record the eating occasion. Starting on the second or third week of intervention, subjects were also counseled to take pictures with their
smart phones before and after consuming their meals. Pictures were typically taken on Sunday, Monday, and Wednesday, every other
week until week 14 (54 meal pictures total). Meal pictures were not taken during intervention weeks 15 and 16 because of the high
burden of post-study experimental testing. The pictures needed to include all study foods prescribed in the menu and a time card and
watch to document the date and eating duration of their meals. Using the time-stamp on the digital picture, the timing of the meal was
crosschecked with the time on the card and watch provided in the picture. Pictures were sent electronically to the study dietitian
whereupon they were assessed for compliance to the meal by identifying the consumption of protein containing meals in the before and
after meal pictures. Meal pictures were specifically used to assess compliance to within-day protein distribution. As such, a subject was
compliant to that eating occasion when they accurately sent a before and after picture of the meal and they consumed all of the prescribed
protein containing foods.

Resistance
Training

Prior to the start of the intervention, subjects were familiarized with the training protocol and exercise equipment. During the
intervention, subjects reported to the A. H. Ismail Center for Health, Exercise and Nutrition, Purdue University, at either 0600 or 1700
for use of weight stack resistance training equipment (TechnoGym, Fairfield, NJ). Subjects completed a readiness-for-exercise
questionnaire prior to each training session to assess their current health status and ability to safely complete a training session. Each
training session lasted ~1 h and included 10-minute warm-up and cool-down periods. During baseline and every fourth week, 1-repetition
maximum (1RM) testing was performed to measure subject’s maximal strength on the following 5 core exercises: chest press, seated
upper back row, seated bilateral leg extension, seated bilateral angled leg presses and seated bilateral leg curl. Subject’s 1RMs were
assessed with multiple single-repetition attempts with defined ranges of motion separated by 2-3 minutes. Measurements were taken on
the same machines used for training. Whole body strength was considered the sum of the 1RMs for 4 core exercises. Seated bilateral
angled leg presses were removed from the analysis of composite whole body strength due to subject’s maximizing the available weight
stack. During the intervention, subjects completed 3 non-consecutive days of resistance training in which they individually performed 3
sets on each of the 5 core exercises along with the seated angled bilateral leg press and 2 additional auxiliary exercises. The hip abductor
and seated shoulder press exercises were alternated every other training session with the latissimus dorsi pull down and hip adductor
exercises. The first set for each exercise was completed in 8-10 repetitions with the last two sets completed to volitional fatigue. In weeks
1, 2, and 3-16 of the intervention, each exercise was performed at 60, 70, and 80% of their most recently measured 1RM, respectively.
All exercises were performed using defined ranges of motion with equal eccentric and concentric contraction time so that each repetition
lasted 4-6 seconds. Subjects rested for 60-90 seconds between each set.
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Appendix A Table 3 continued. Detailed procedures used for assessing subjects in the EVEN and SKEW groups while consuming an energy-restricted diet and
performing resistance training for 16 wk
Anthropometry

Magnetic
resonance
imaging (MRI)

Body composition was measured via dual energy X-ray absorptiometry in the morning after a 10-12 h fast. Subjects were encouraged to
consume fluids the day before testing, were permitted to consume water on the morning of testing, and voided their bladder premeasurement. Defecation was not monitored or controlled. During the entirety of the procedure, subjects remained in a supine position.
Height was measured without shoes at pre-intervention using a wall-mounted stadiometer (Holtain Ltd, Crymych, Wales, United
Kingdom). BMI were calculated at pre- and post-intervention using whole body mass from DXA and baseline body height. Body
circumference was measured in triplicate at the natural waist and hip using a spring tape measure.
Subjects arrived at the Purdue University MRI facility after an overnight fast and 48 h of limited physical activity prior to scanning.
Upon arrival, the subject’s calf and thigh lengths were measured from the bony protrusion on the lateral side of the knee to the distalmost location below the ankle bulge and from the lateral and medial bony protrusions of the knee to the inguinal crease, respectively.
Sixty-six percent of the calf length starting from below the ankle bulge and 50% of the thigh length starting from the bony protrusions
were marked using a vitamin E capsule taped to skin at the designated site. Forty-five minutes prior to scanning, subjects laid in the
supine position on a gurney to control for the influence of posture-related fluid shifts on muscle size. After transferring to the scanner
table from the gurney while remaining supine, the subject’s heels were fixed on a nonmetallic support in order to control joint and scan
angle and to minimize compression of the legs against each other and the MRI gurney. Specific foot angles were recorded to create a
reproducible position for the post-intervention scans. Subjects were positioned in the MRI scanner in a feet-first direction using the
vitamin E capsule as the external landmark. The scanning sequence was positioned to image the thigh by placing the inferior-most slice
at the top of the tibial notch and calf by placing the superior-most slice at the bottom of the tibial notch on the subject's right leg. Axial
T1-weighted scans were acquired using an 8-channel nee array coil (calf) and an 8-channel torso array coil (thigh) (Invivo Corporation,
Gainesville, FL)k. A three-plane fast gradient echo scout scan established the location of the tibial notch. Scan parameters for the thigh
were: repetition time/echo time (TR/TE) = 5/1.6ms; field-of-view (FOV) = 48cm; acquisition matrix = 256x128; slice thickness = 5mm;
20 axial slices, interslice spacing = 20mm; 40 coronal slices, interslice spacing = 0mm; 2 sagittal slices, interslice spacing = 10mm.
Those for the calf are: repetition time/echo time (TR/TE) = 6/2.5ms; field-of-view (FOV) = 30cm; acquisition matrix = 256x128; slice
thickness = 3mm; 15 axial slices, interslice spacing = 0mm; 30 coronal slices, interslice spacing = 0.5mm; 30 sagittal slices, interslice
spacing = 0.5mm. The localizer scans were followed by high-resolution imaging of the thigh and calf regions. In each case, a fast spin
echo sequence [TR/TE = 600/12 ms; FOV = 16cm for calf and 22cm for thigh; acquisition matrix = 384x224 for calf and 384x192 for
thigh; slice thickness = 8mm; 24-36 axial slices, interslice spacing = 0mm; number of excitations (NEX) = 3] were performed. Image
files were transferred to a personal computer and analyzed using Medical Image processing, Analysis and Visualization (MIPAV) from
NIH. For all subjects, 4-7 slices (dependent upon height) were chosen to be analyzed for the thigh (superior slice is where the gluteus
muscle disappears, inferior slice is before the rectus muscle appears, every third slice was traced), and 6-7 slices were analyzed for the
calf (superior slice is where peroneus longus appears, inferior slice is where the gastrocnemius disappears, every third slice was traced).
All images were corrected using inhomogeneity N3 correction. Total area, intermuscular adipose tissue, muscle, and subcutaneous fat
contents of the thigh and calf were quantified using Fuzzy C-means algorithm. Data were reported using average area of all traced slices
for mid- thigh and calf areas.
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Appendix A Table 4. Subject’s habitual, prescribed, and week 16 nutrient intakes in the EVEN and SKEW groups while consuming an energy-restricted diet and
performing resistance training for 16 wk 1,2
EVEN
Nutritional information

SKEW

Habitual

Prescribed

Week 16

Habitual

Prescribed

Week 16

2131 ± 116a

1779 ± 110ab

1571 ± 113b

2210 ± 116a

1794 ± 113ab

1556 ± 116b

Carbohydrate (%En)

48 ± 2a

53 ± 2ab

48 ± 2a

49 ± 2a

52 ± 2ab

59 ± 2b

Protein (%En)

16 ± 1a

21 ± 1b

23 ± 1b

16 ± 1a

21 ± 1b

24 ± 1b

Fat (%En)

36 ± 1a

26 ± 1b

30 ± 1bc

35 ± 1ac

26 ± 1b

26 ± 1b

255 ± 16ac

238 ± 16ab

192 ± 16b

266 ± 16a

238 ± 16ab

198 ± 16bc

Protein (g/d)

82 ± 4

90 ± 4

89 ± 4

90 ± 4

91 ± 4

91 ± 4

Fat (g/d)

86 ± 6a

52 ± 5b

52 ± 6b

87 ± 6a

54 ± 6b

45 ± 6b

0.89 ± 0.05a

0.99 ± 0.04ab

1.07 ± 0.04b

0.98 ± 0.04ab

1.00 ± 0.04ab

1.09 ± 0.04ab

Energy (kcal/d)

Carbohydrate (g/d)

Protein (g/kg/d)
1

Data are presented as LSmean ± SE of the LSmeans; A repeated-measure ANOVA (MIXED procedure, SAS version 9.3; SAS Institute) was used to test for
differences between groups in habitual, prescribed, and week 16 for nutrient intakes. Carbohydrates were reduced during the intervention to maintain a
constant weight loss of approximately 0.5 kg/wk. Values within the same row with different superscript letters indicate significant difference, Tukey adjusted
P < 0.05
2
Habitual: EVEN: n= 5 males and 14 females, SKEW: n= 9 males and 10 females, Prescribed: EVEN: n= 6 males and 15 females, SKEW: n= 9 males and 11
females; Week 16: EVEN: m= 5 males and 15 females, SKEW: n = 9 males and 10 females.
Abbreviations: EVEN, 30 g of protein consumed at breakfast, lunch, and dinner; SKEW, 10 g of protein consumed at breakfast, 20 g at lunch, and 60 g at
dinner; Habitual, subjects intake prior to initiating the study assessed using 3-d recall; Prescribed, subjects average nutrition intake as prescribed by the study
dietitian at week 1. Week 16, the subject’s actual intake as assessed at week 16 of the intervention using 3-day analysis of menu checkoff sheets; %EN,
percentage of energy
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Appendix A Table 5. Subject’s reported within-day nutrient intake distribution during the last week of the intervention in the EVEN and SKEW groups while
consuming an energy-restricted diet and performing resistance training for 16 wk 2
EVEN

SKEW

Nutritional information
Total (d)

Breakfast

Lunch

Dinner

Total (d)

Breakfast

Lunch

Dinner

1567 ± 46

407 ± 19

566 ± 16

600 ± 21

1509 ± 55

327 ± 10*

529 ± 18

660 ± 35

—

26 ± 1

36 ± 1

38 ± 1

—

21 ± 1*

34 ± 1*

42 ± 1*

191 ± 11

45 ± 4

65 ± 4

81 ± 5

187 ± 11

55 ± 3

75 ± 4

59 ± 6*

Fat (g)

52 ± 1

11 ± 1

22 ± 1

20 ± 1

44 ± 1

8 ± 0*

17 ± 0*

19 ± 1

Protein (g)

89 ± 1

31 ± 1

29 ± 0

29 ± 0

91 ± 1

11 ± 0*

20 ± 1*

59 ± 1*

Protein (%)

—

35 ± 1

33 ± 1

33 ± 0

—

12 ± 0*

22 ± 0*

65 ± 1*

1.07 ± 0.03

0.38 ± 0.01

0.35 ± 0.01

0.35 ± 0.01

1.09 ± 0.03

0.13 ± 0.01*

0.24 ± 0.01*

0.71 ± 0.02*

Energy (kcal)
Energy (%)
Carbohydrate (g)

Protein (g/kg)
1

Data are presented as mean ± SEM; An unpaired, two-tailed t-test (TTEST procedure, SAS version 9.3; SAS Institute) was used to test for differences
between group total, breakfast, lunch, and dinner nutrition information from 3-d menu checklists during the final week of the intervention. Menu checklists
included any deviations from the prescribed menu
2
EVEN: n= 5 males and 15 females, SKEW: n = 9 males and 10 females
*Indicates a significant difference between groups within outcome variable, P < 0.05.
Abbreviations: EVEN, 30 g of protein consumed at breakfast, lunch, and dinner; SKEW, 10 g of protein consumed at breakfast, 20 g at lunch, and 60 g at
dinner
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Appendix A Table 6. Diet and exercise compliance in the EVEN and SKEW groups while consuming an energyrestricted diet and performing resistance training for 16 wk 1,2
EVEN

SKEW

Menu checklist compliance (%)3

92 ± 2 (94)

88 ± 2 (92)

Total non-compliant meals (#)3

24 ± 5 (18)

37 ± 7 (23)

Menu deviation

2 ± 1 (0)

4 ± 2 (2)

Missing food item

7 ± 2 (3)

12 ± 4 (5)

Not recorded

15 ± 4 (6)

20 ± 7 (9)

Meal picture compliance (%)4

80 ± 4 (87)

82 ± 3 (85)

Total non-compliant pictures (#)4

11 ± 2 (7)

10 ± 2 (8)

Missing pictures

9 ± 2 (5)

8 ± 2 (7)

Missing protein containing foods

1 ± 0 (0)

1 ± 0 (0)

Other

1 ± 1 (0)

0 ± 0 (0)

86 ± 2 (85)a

91 ± 2 (93)b

Parameter

Exercise compliance (%)3
1

Data are presented as mean ± SEM (median); An unpaired, two tailed t-test (TTEST procedure, SAS version 9.3;
SAS Institute) was used to test for differences in dietary and exercise compliance. Different letters indicate a
significant difference between groups within row, P < 0.05.
2
294 and 54 meals were evaluated from menu checklists and meal pictures, respectively, for each subject.
3
EVEN: n= 6 males and 15 females, SKEW: n= 9 males and 11 females
4
EVEN: n= 5 males and 15 females, SKEW: n= 8 males and 11 females
Abbreviations: EVEN, 30 g of protein consumed at breakfast, lunch, and dinner; SKEW, 10 g of protein
consumed at breakfast, 20 g at lunch, and 60 g at dinner
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Appendix B Table 1. Search terms
Database
PubMed

Search criteria
((Dietary Protein[MeSH]) AND (Body composition[Mesh] OR "Weight Loss"[Mesh] OR "Body Weight Maintenance"[Mesh] OR "Weight
Gain"[Mesh] OR Strength, Muscle[MeSH] OR Muscle, Skeletal[Mesh]))
Limitations
1. Humans
2. English
3. Adults: 19+ years

Cochrane
Review

("Dietary protein" or "Protein Supplementation" or "protein supplement") and ("lean mass" or "fat mass" or "Muscle mass" or "body
composition")

Scopus

("Dietary protein" OR "protein intake" OR "protein supplement" OR "high protein") AND ( "body composition" OR "lean mass" OR "fat
mass" OR "fat free mass" ) AND ( "Weight loss" OR "energy restriction" OR exercise OR "resistance training" OR "aerobic training" OR
"weight maintenance" OR "weight gain") AND NOT ( animals OR rats OR mice OR cells OR children OR adolescent) AND ( LIMITTO(SUBJAREA," BIOC" ) OR EXCLUDE(SUBJAREA,"MEDI OR LIMIT-TO SUBJAREA " ) ) AND ( LIMIT-TO(DOCTYPE,"ar" ) )
AND ( EXCLUDE(EXACTSRCTITLE,"Aquaculture OR EXCLUDE EXACTSRCTITLE " ) OR EXCLUDE(EXACTSRCTITLE," Journal of
the World Aquaculture Society" ) OR EXCLUDE(EXACTSRCTITLE,"Aquaculture Nutrition" ) ) AND ( LIMITTO(LANGUAGE,"English" ) ) AND ( EXCLUDE(SUBJAREA,"NURS" ) ) AND ( EXCLUDE(SUBJAREA,"HEAL" ) OR
EXCLUDE(SUBJAREA,"EART" ) ) AND ( EXCLUDE(SUBJAREA,"IMMU" ) OR EXCLUDE(SUBJAREA,"NEUR" ) ) AND
( EXCLUDE(SUBJAREA,"ARTS" ) OR EXCLUDE(SUBJAREA,"CENG" ) ) AND ( EXCLUDE(SUBJAREA,"PHAR" ) OR
EXCLUDE(SUBJAREA,"SOCI" ) )
1. Limits: Document Type (Articles, Articles in Press)
2. Source Type (Journals)
3. Subject Area (Medicine, Biochemistry, Genetics and Molecular Biology, Agricultural and biological sciences)
4. Language (English)
((MM "Dietary Proteins+") OR (MM “Diet, High Protein+”) OR “dietary protein” OR “protein intake” OR “protein supplement” OR “high
protein”) AND ((MM “Weight Loss+”) OR (MM “Weight Reduction Programs+”) OR (MM “Restricted Diet+”) OR (MM “Body Weight
Changes”) OR “weight maintenance” OR “weight gain” OR “energy restriction” OR “low calorie” OR “weight loss” OR (MM “Body Weight
Changes+”) OR “weight reduction” OR “fat loss” OR “energy intake” OR weight OR restriction OR energy OR reduction) AND ((MM
“Exercise+”) OR (MM “Therapeutic Exercise+”) OR (MM “Resistance Training+”) OR (MM “Weight Lifting+”) OR “exercise intervention”
OR “body composition” OR muscle OR “fat mass” OR “lean mass” OR fat free mass”)

CINAHL
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Appendix B Table 2. Risk of bias assessment of randomized controlled trials included in a systematically searched qualitative assessment on the effects of
consuming a protein-rich supplement versus between meals on body composition changes in resistance training adults 1
Selection bias
Author, year

Randomization

Allocation
concealment

Performance
bias
Blinding of
participants
and personnel

Arciero et al.
(2006)(256)

Unclear

Unclear

Unclear

Arciero et al.
(2008)(257)

Unclear

Unclear

Unclear

Detection
bias
Blinding of
outcome
Dietary prescription
assessment
PRO-WITH
Provided meal
replacements; verbal and
written dietary
Unclear
instructions; met weekly
with dietician; monthly
group meetings
Provided meal
replacements; 7-d menu
cycle; verbal and written
Unclear
dietary instructions;
monthly group meetings

Dietary control
Dietary compliance

Daily food record throughout intervention;
3-d food record prior to testing day; daily
subject-researchers contact; completed food
logs turned in weekly; counted empty
supplement containers
Daily subject-researchers contact;
completed food logs turned in weekly;
counted empty supplement containers

Chalé et al.
(2013)(231)

Unclear

Low risk

Low risk

Unclear

Provided supplement

Consumed supplement under supervision;
measured urine PABA; counted empty
supplement containers; Completed 3-d
weighted food record at 0 and 6 m

Gryson et al.
(2014)(258)

Unclear

Unclear

Low risk

Unclear

Provided supplement;
Group counseling
sessions

Completed 3-d weighted food record at 1
and 16 wk;

Leenders et
al.
(2013)(232)

Unclear

Unclear

Low risk

Unclear

Provided supplement

Completed 4-d weighted food record before
and after every 4 wk;

Provided supplement;
Diet consisted of a
repeating 4-wk rotating
menu

A trained dietitian used a calibrated dietetic
spring scale to weigh all foods served and
returned for 3 consecutive days at the
beginning and end of the study. Nurses who
served any foods to the participants between
meals recorded the amount eaten, in
household measurements.

Rondanelli et
al.
(2016)(259)

Low risk

Low risk

Low risk

Low risk
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Appendix B Table 2 Continued. Risk of bias assessment of randomized controlled trials included in a systematically searched qualitative assessment on the
effects of consuming a protein-rich supplement versus between meals on body composition changes in resistance training adults 1
Tieland et al.
(2012)(229)

Low risk

Unclear

Low risk

Unclear

Provided supplement; dietary counseling
provided by dietician

Volek et al.
(2013)(260)

Unclear

Unclear

Low risk

Unclear

Provided supplement; dietary counseling
provided by dietician; customized dietary
program

Weinheimer et
al. (2012)(249)

Unclear

Unclear

Low risk

Unclear

Provided supplement

Complete 5-d food record ever 6 wk;
consumed supplement under supervision;
completed supplemental log; counted
empty supplement containers; measured
urine PABA
Completed 4-d food records at 0, 18, and
36 wk; measured UUR; completed daily
supplement logs;

PRO-BET
Completed weekly supplement journals;
counted empty supplement containers; 3day food record at the beginning and end
Consumed supplement under supervision;
completed 3-d weight food record
completed 3-d weighted food record at 1
and 6 wk; verbal communication; counted
empty supplement containers

Arciero et al.
(2014)(261)

Unclear

Unclear

Unclear

Unclear

Provided supplement; monthly group meetings

Arnarson et al.
(2013)(262)

Low risk

Low risk

Low risk

Low risk

Provided supplement

Candow et al.
(2006)(263)

Unclear

Unclear

Low risk

Low risk

Provided supplement

Unclear

Unclear

Low risk

Low risk

Provided supplement

Completed 3-d food record at 1 and 12 wk

Unclear

Unclear

Low risk

Low risk

Provided supplement

Counted empty supplement bags

Cribb et al.
(2006)(266)

Unclear

Unclear

Low risk

Unclear

Provided supplement

Cribb et al.
(2007)(267)

Unclear

Unclear

Low risk

Low risk

Provided supplement

Candow et al.
(2006)(264)
Candow et al.
(2008)(265)

Counted empty supplement containers;
completed 3-d weighted food record 0, 1,
and 10 wk
Counted empty supplement containers;
supplement ingestion date/time was
recorded daily; completed 3-d weighted
food record once at the beginning and
twice during the intervention
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Appendix B Table 2 Continued. Risk of bias assessment of randomized controlled trials included in a systematically searched qualitative assessment on the
effects of consuming a protein-rich supplement versus between meals on body composition changes in resistance training adults 1

Unclear

Unclear

Low risk

Unclear

Provided supplement

Counted empty supplement containers;
supplement ingestion date/time was recorded
daily; completed 3-d weighted food record
once at the beginning and twice during the
intervention

Low risk

Unclear

Low risk

Unclear

Provided supplement

Supplement log; returned excess supplement

Unclear

Unclear

Low risk

Unclear

Provided supplement

Consumed supplement under supervision;
completed 3-d food record 1 and 14 wk

Low risk

Unclear

Unclear

Unclear

Provided supplement

Completed 4-d food record

Unclear

Unclear

Low risk

Unclear

Provided supplement

Consumed pre RT supplement under
supervision; counted empty supplement
containers

Unclear

Unclear

Unclear

Unclear

Provided supplement

Subjects were asked to record dietary intake.

Unclear

Unclear

Low risk

Unclear

Provided supplement

Unclear

Unclear

Low risk

Unclear

Provided supplement

Joy et al.
(2013)(276)

Low risk

Unclear

Low risk

Unclear

Kerksick et al.
(2006)(277)

Unclear

Unclear

Low risk

Unclear

Kerksick et al.
(2007)(278)

Unclear

Unclear

Low risk

Unclear

Cribb et al.
(2007)(268)
Duff et al.
(2014)(269)
Eliot et al.
(2008)(270)
Esmarck et al.
(2001)(271)
Herda et al.
(2013)(272)
Hoffman et al.
(2007)(273)
Hoffman et al.
(2009)(274)
Holm et al.
(2008)(275)

Provided supplement; met with
dietician prior to starting the
intervention
Provided supplement;
Investigators provided detailed
instruction on portion sizes as
well as general information
regarding food preparation
Provided supplement; instructed
to maintain habitual intake

Counted empty supplement containers;
completed 3-d food record 0 and 9 wk
Completed 4-d weighted food record at 0, 12,
and 24 wk;
Consumed supplement under supervision

Counted empty supplement containers;
completed 4-d weighted food record 0, 2, 5, 8,
and 10 wk
Supplement ingestion date/time was recorded
daily; counted empty supplement containers;
completed 3-d weighted food record
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Appendix B Table 2 Continued. Risk of bias assessment of randomized controlled trials included in a systematically searched qualitative assessment on the
effects of consuming a protein-rich supplement versus between meals on body composition changes in resistance training adults 1
Rozenek et al.
(2002)(279)
Snijders et al.
(2001)(280)
Tarnopolsky et
al. (2001)(281)
Taylor et al.
(2015)(282)
Verdijk et al.
(2009)(283)
Weisgarber et al.
(2012)(284)

Low risk

Low risk

Low risk

Low risk

Provided supplement;
instructed to maintain
habitual intake

3-d diet histories were collected during the
1st, 4th, and 8th week of the study

Unclear

Unclear

Low risk

Unclear

Provided supplement

Completed 3-d weighted food record at 0
and 11 wk

Unclear

Unclear

Low risk

Unclear

Unclear

Unclear

Unclear

Unclear

Provided supplement

Unclear

Unclear

Unclear

Unclear

Provided supplement

Unclear

Unclear

Low risk

Unclear

Consumed supplement under supervision

Provided supplement;
instructed to maintain
habitual intake
1
Risk of bias assessed using the Cochrane Collaboration tool for randomized controlled trials
Willoughby et
al. (2007)(285)

Unclear

Unclear

Low risk

Unclear

Consumed supplement under supervision
Completed 3-d weighted food record at 0
and 11 wk
Completed 3-d weighted food record at 0
and 11 wk; verbal communication
Counted empty supplement containers;
complete 7-d food record 0, 5, and 10 wk
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Appendix B Table 3. Descriptions of the randomized controlled trials included in a systematically searched
qualitative assessment on the effects of consuming a protein-rich supplement versus between meals on body
composition changes in resistance training adults 1

Author, year

Subject details
Age
n
(y)
Sex

Training
status

Resistance training details
Frequency
(d/wk)
Length (wk)

PRO-WITH
Arciero et al. (2006)(256)
Arciero et al. (2008)(257)
––––––––––––
Chalé et al. (2013)(231)
Gryson et al. (2014)(258)
––––––––––––
––––––––––––
Leenders et al. (2013)(232)
––––––––––––
Rondanelli et al. (2016)(259)
Tieland et al. (2012)(229)
Volek et al. (2013)(260)
––––––––––––
Weinheimer et al.
(2012)(249)
––––––––––––
––––––––––––

27
8
8
42
9
10
8
12
15
61
28
19
22

42
42
44
78
61
61
61
72
70
81
78
23
24

M+F
M+F
M+F
M
M
M
M
F
M
M+F
M+F
M+F
M+F

UT
UT
UT
UT
UT
UT
UT
UT
UT
UT
UT
UT
UT

6
6
6
3
3
3
3
3
3
5
2
2-3
2-3

12
36
36
24
16
16
16
24
24
12
24
36
36

65

47

M+F

UT

2-3

36

16
23

46
50

M+F
M+F

UT
UT

2-3
2-3

36
36

4
4
3
3
3
3
3
3
4
4
4
4
?
?
?
3
3
3
3
3
3

16
16
12
12
12
10
6
6
10
10
11
11
10
10
10
8
8
14
14
12
12

PRO-BET
Arciero et al. (2014)(261)
––––––––––––
Arnarson et al. (2013)(262)
Candow et al. (2006)(263)
––––––––––––
Candow et al. (2006)(264)
Candow et al. (2008)(265)
––––––––––––
Cribb et al. (2006)(266)
––––––––––––
Cribb et al. (2007)(267)
––––––––––––
Cribb et al. (2007)(268)
––––––––––––
––––––––––––
Duff et al. (2014)(269)
––––––––––––
Eliot et al. (2008)(270)
––––––––––––
Esmarck et al. (2001)(271)
––––––––––––

17
22
83
10
9
10
9
9
8
9
5
6
10
10
11
19
21
11
11
7
6

52
47
73
67
64
67
24
23
21
24
24
25
25
26
26
62
58
48-72
48-72
74
73

M+F
M+F
M+F
M
M
M
M+F
M+F
M
M
M
M
M
M
M
M+F
M+F
M
M
M
M

UT
UT
UT
UT
UT
N/A
UT
UT
T
T
T
T
T
T
T
N/A
N/A
N/A
N/A
UT
UT

110
Appendix B Table 3 Continued. Descriptions of the randomized controlled trials included in a systematically
searched qualitative assessment on the effects of consuming a protein-rich supplement versus between meals on
body composition changes in resistance training adults 1
Herda et al. (2013)(272)
22 21
M
UT
3
8
––––––––––––
20 21
M
UT
3
8
––––––––––––
22 21
M
UT
3
8
Hoffman et al. (2007)(273)
11 20
M
T
4
12
Hoffman et al. (2009)(274)
13 20
M
T
4
10
––––––––––––
13 20
M
T
4
10
Holm et al. (2008)(275)
13 55
F
N/A
2-3
8
Joy et al. (2013)(276)
12 21
M
T
2
8
––––––––––––
12 21
M
T
2
8
Kerksick et al. (2006)(277)
15 31
M
T
4
10
––––––––––––
10 31
M
T
4
10
Kerksick et al. (2007)(278)
12 27 M+F
T
4
12
––––––––––––
13 27 M+F
T
4
12
––––––––––––
13 27 M+F
T
4
12
––––––––––––
11 27 M+F
T
4
12
Rozenek et al. (2002)(279)
26 23
M
UT
4
8
Snijders et al. (2001)(280)
19 23
M
UT
3
12
Tarnopolsky et al. (2001)(281)
8
24
M
UT
6
8
Taylor et al. (2015)(282)
8
20
F
T
4
8
Verdijk et al. (2009)(283)
13 72
M
UT
3
8
Weisgarber et al. (2012)(284)
9
25 M+F
UT
4
8
Willoughby et al. (2007)(285)
10 19
M
UT
4
10
1
Individual study details regarding subject characteristics (n, age, sex, and resistance training status),
resistance training details (training frequency and study length), and protein supplementation details
(Type of protein, amount of protein (g/d), and prescribed timing); BCAA, branched-chain amino acids;
EAA, essential amino acids, F, female; M, male; N/A, not available; PRO-WITH, groups ingesting
protein supplements with meals; PRO-BET, groups ingesting protein supplements between meals; RT,
resistance training; T, trained; UT, untrained.

Appendix B Table 4. Descriptions of the randomized controlled trials included in a systematically searched qualitative assessment on the effects of consuming a
protein-rich supplement versus between meals on body composition changes in resistance training adults 1
Protein supplementation details
Author, year

Type of protein

Amount of protein
(g/d)
RT
Non-RT
day
days

Prescribed timing
RT days

Non-RT days

PRO-WITH
Arciero et al. (2006)(256)

Replaced 3 meals

Replaced 3 meals

75

Replaced 3 meals

Replaced 3 meals

39

39

Replaced 3 meals

Whey

40

40

Milk protein
Milk protein
Milk protein

10
10
10

10
10
10

Replaced 3 meals
After breakfast + post
RT
Post RT
Post RT
Post RT

Milk protein

15

15

After breakfast

After breakfast

Milk protein

15

15

After breakfast

After breakfast

Whey protein + EAA

22

22

With lunch

With lunch

Milk protein

30

30

Whey
Soy

22
20

22
20

Whey

20

20

––––––––––––

Whey

40

40

––––––––––––

Whey

60

60

Arciero et al. (2008)(257)
––––––––––––
Chalé et al. (2013)(231)
Gryson et al. (2014)(258)
––––––––––––
––––––––––––
Leenders et al.
(2013)(232)
––––––––––––
Rondanelli et al.
(2016)(259)
Tieland et al. (2012)(229)
Volek et al. (2013)(260)
––––––––––––
Weinheimer et al.
(2012)(249)

Meal replacement
Milk protein + casein +
whey
Meal replacement

75

After breakfast + after
lunch
Post RT
Post RT
With breakfast + with
lunch
With breakfast + with
lunch
With breakfast + with
lunch

After breakfast + after dinner
With breakfast
With breakfast
With breakfast

After breakfast + after lunch
With breakfast
With breakfast
With breakfast + with lunch
With breakfast + with lunch
With breakfast + with lunch
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Appendix B Table 4 Continued. Descriptions of the randomized controlled trials included in a systematically searched qualitative assessment on the effects of
consuming a protein-rich supplement versus between meals on body composition changes in resistance training adults 1
PRO-BET
Arciero et al. (2014)(261)
––––––––––––
Arnarson et al. (2013)(262)
Candow et al. (2006)(263)
––––––––––––
Candow et al. (2006)(264)
Candow et al. (2008)(265)
––––––––––––
Cribb et al. (2006)(266)
––––––––––––
Cribb et al. (2007)(267)
––––––––––––

Whey
Whey
Whey
Whey
Whey
Whey
Whey
Soy
whey
whey
Whey
Whey

60
60
20
26
26
75
83
86
82
78
90
90

40
40
0
0
0
0
83
86
0
0
90
90

Waking + pre RT + before bed
Waking + pre RT + before bed
Post RT
Post RT
Pre RT
Pre RT + post RT + before bed
Pre RT + post RT + before bed
Pre RT + post RT + before bed
Pre RT + post RT
Before breakfast + before bed
Mid-morning + post RT + evening
Mid-morning + post RT + evening

Whey

113

113

Mid-morning + post RT + before bed

––––––––––––

Whey

54

54

Mid-morning + post RT + before bed

––––––––––––
Duff et al. (2014)(269)
––––––––––––
Eliot et al. (2008)(270)
––––––––––––
Esmarck et al. (2001)(271)
––––––––––––
Herda et al. (2013)(272)
––––––––––––
––––––––––––

Whey

53

53

Mid-morning + post RT + before bed

Bovine colostrum
Whey
Whey
Whey
Milk proteins + soy
Milk proteins + soy
Whey + leucine
Whey + leucine
Whey

38
38
35
35
10
10
40
40
40

38
38
0
0
0
0
0
0
0

Pre RT + post RT + discretion
Pre RT + post RT + discretion
Post RT
Post RT
Post RT
2 h Post RT
Pre RT + post RT
Pre RT + post RT
Pre RT + post RT

Cribb et al. (2007)(268)

Waking + before bed
Waking + before bed
––––––––––––
––––––––––––
––––––––––––
––––––––––––
Similar time as RT days + before bed
Similar time as RT days + before bed
––––––––––––
––––––––––––
Mid-morning + similar time as RT days + evening
Mid-morning + similar time as RT days + evening
Mid-morning + similar time as RT days + before
bed
Mid-morning + similar time as RT days + before
bed
Mid-morning + similar time as RT days + before
bed
Discretion
Discretion
––––––––––––
––––––––––––
––––––––––––
––––––––––––
––––––––––––
––––––––––––
––––––––––––

112

Appendix B Table 4 Continued. Descriptions of the randomized controlled trials included in a systematically searched qualitative assessment on the effects of
consuming a protein-rich supplement versus between meals on body composition changes in resistance training adults 1
Hoffman et al. (2007)(273)
Hoffman et al. (2009)(274)
––––––––––––
Holm et al. (2008)(275)
Joy et al. (2013)(276)
––––––––––––
Kerksick et al. (2006)(277)
––––––––––––
Kerksick et al. (2007)(278)
––––––––––––
––––––––––––
––––––––––––

Protein blend
Collagen + whey + casein
Collagen + whey + casein
Whey
Whey
Rice
Whey + BCAA + glutamine
Whey + casein
Whey + casein
Whey + casein + colostrum
Whey + casein
Whey + casein + colostrum

84
42
42
10
48
48
48
48
75
75
75
75

42
42
42
0
0
0
48
48
75
75
75
75

Morning + post RT
Morning + evening
Pre RT + post RT
Post RT
Post RT
Post RT
Post RT
Post RT
Post RT
Post RT
Post RT
Post RT
Between breakfast/lunch + before
bed
Before bed

Morning
Morning + evening
Similar time as RT days
––––––––––––
––––––––––––
––––––––––––
Morning
Morning
Morning
Morning
Morning
Morning
Between breakfast/lunch
+ before bed
Before bed
––––––––––––

Protein blend
106
106
Rozenek et al. (2002)(279)
Snijders et al. (2001)(280)
Casein
28
28
Tarnopolsky et al.
Casein
10
0
Post RT
(2001)(281)
Taylor et al. (2015)(282)
Whey protein
48
0
Pre RT + post RT
––––––––––––
Verdijk et al. (2009)(283)
Casein
20
0
Pre RT + post RT
––––––––––––
Weisgarber et al.
––––––––––––
Whey
26
0
Pre RT + during RT
(2012)(284)
Willoughby et al.
Whey + milk protein + casein +
40
40
1 h pre RT + post RT
Morning
(2007)(285)
EAA
1
Individual study details regarding subject characteristics (n, age, sex, and resistance training status), resistance training details (training frequency and
study length), and protein supplementation details (Type of protein, amount of protein (g/d), and prescribed timing); BCAA, branched-chain amino acids;
EAA, essential amino acids, F, female; M, male; N/A, not available; PRO-WITH, groups ingesting protein supplements with meals; PRO-BET, groups
ingesting protein supplements between meals; RT, resistance training; T, trained; UT, untrained.
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Appendix B Table 5. Qualitative assessment on the directional effect of consuming a protein supplement with versus between meals on body composition
changes in resistance training adults1,2,3
≥ protein dose
estimated to
Young and middleOlder adults
maximize muscle
All interventions
12-16 wk in duration aged adults (≤ 50 y)
(> 50 y)
protein synthesis4
PROPROPROPROPROPROPROPROPROPROOutcome
WITH
BET
WITH
BET
WITH
BET
WITH
BET
WITH
BET
Body mass, kg
↓
?
↑
?
?
↑
↑
?
↔
↑
Lean mass, kg
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
Fat mass, kg
↓
↓
↓
↓
↓
↓
?
?
?
?
Lean:fat mass ratio
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
1
Codes represent summary of effect. Inconsistent effect (?): 34-66% of groups reported either an increase or decrease from baseline; consistent
positive (increase) (↑) or negative (decrease) (↓) effect: 67-100% of groups reported a change in that direction from baseline; PRO-WITH, groups
ingesting protein supplements with meals; PRO-BET, groups ingesting protein supplements between meals.
2
Each body composition analysis is composed of a different sample size
3
The type of protein-rich supplement varied across groups; some studies have contributed more than one intervention group
4
Analysis only includes protein doses from supplements that are ≥ 0.24 and 0.40 g/kg/body mass in younger and older adults, respectively. This
was calculated by dividing the protein dose by the group mean body mass.
5
Analysis only includes intervention that supplemented between 10 and 75 g of protein/d. This was selected based on the lower and upper
quantities that were available for comparison in both groups.
6
Analysis only includes interventions that reported total protein intakes between 0.9-1.6 g protein/kg/d.
7
Analysis only includes interventions that supplemented between 10 and 75 g of protein/d and reported total protein intakes between 0.9-1.6 g
protein/kg/d.
8
Analysis only includes interventions that did not include creatine supplementation; only the PRO-BET category contained groups that
supplemented with creatine, therefore, the results in PRO-WITH are unchanged from the original analysis.
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Appendix B Table 5 Continued. Qualitative assessment on the directional effect of consuming a protein supplement with versus between meals on body
composition changes in resistance training adults1,2,3

Outcome

All interventions
PROPROWITH
BET
?
↑
↑
↑
↓
?

Range matched for
total protein
supplemented5
PROPROWITH
BET
?
?
↑
↑
↓
↓

Range matched for
total protein intake6
PROPROWITH
BET
↑
?
↑
↑
↓
↓

Range matched for
total protein
supplemented and
total protein intake7
PROPROWITH
BET
↑
?
↑
↑
↓
↓

No creatine
supplementation8
PROPROWITH
BET
↔
↑
↑
↑
↓
↓

Body mass, kg
Lean mass, kg
Fat mass, kg
Lean:fat mass
↑
↑
↑
↑
↑
↑
↑
↑
↑
↑
ratio
1
Codes represent summary of effect. Inconsistent effect (?): 34-66% of groups reported either an increase or decrease from baseline; consistent
positive (increase) (↑) or negative (decrease) (↓) effect: 67-100% of groups reported a change in that direction from baseline; PRO-WITH,
groups ingesting protein supplements with meals; PRO-BET, groups ingesting protein supplements between meals.
2
Each body composition analysis is composed of a different sample size
3
The type of protein-rich supplement varied across groups; some studies have contributed more than one intervention group
4
Analysis only includes protein doses from supplements that are ≥ 0.24 and 0.40 g/kg/body mass in younger and older adults, respectively. This
was calculated by dividing the protein dose by the group mean body mass.
5
Analysis only includes intervention that supplemented between 10 and 75 g of protein/d. This was selected based on the lower and upper
quantities that were available for comparison in both groups.
6
Analysis only includes interventions that reported total protein intakes between 0.9-1.6 g protein/kg/d.
7
Analysis only includes interventions that supplemented between 10 and 75 g of protein/d and reported total protein intakes between 0.9-1.6 g
protein/kg/d.
8
Analysis only includes interventions that did not include creatine supplementation; only the PRO-BET category contained groups that
supplemented with creatine, therefore, the results in PRO-WITH are unchanged from the original analysis.

115

Appendix B Table 6. Qualitative assessment on the magnitude of effect of consuming a protein supplement with versus between meals on body composition
changes in resistance training adults 1,2,3

Amount of change
Body mass (kg)
< 10 to ≥ 5 kg gain
< 5 to ≥ 0 kg gain
> 0 to < 5 kg loss
≥ 5 to < 10 kg loss
Body mass (%)
< 10 to ≥ 5 % gain
<±5%
≥ 5 to < 10 % loss
Lean mass (kg)
≥ 3 kg gain
< 3 to ≥ 1.5 kg gain
< 1.5 to ≥ 0 kg gain
> 0 to < 1.5 kg loss
Lean mass (%)
< 10 to ≥ 5 % gain
< 5 to ≥ 0 % gain
> 0 to < 5 % loss
Fat mass (kg)
< 5 to ≥ 0 kg gain
> 0 to < 5 kg loss
≥ 5 to ≤ 10 kg loss
Fat mass (%)
< 10 to ≥ 5 % gain
<±5%
≥ 5 to < 10 % loss
≥ 10 % loss

≥ protein dose
estimated to
maximize muscle
protein synthesis4
PROPROWITH
WITH

All interventions
PROWITH
PRO-BET

12-16 wk in duration
PROWITH
PRO-BET

Young and middleaged adults (≤ 50 y)
PROWITH
PRO-BET

0 (0)
56 (9)
25 (4)
19 (3)

8 (3)
64 (23)
28 (10)
0 (0)

0 (0)
29 (2)
29 (2)
42 (3)

0 (0)
62 (8)
38 (5)
0 (0)

0 (0)
43 (3)
14 (1)
43 (3)

12 (3)
69 (18)
19 (5)
0 (0)

0 (0)
67 (6)
33 (3)
0 (0)

0 (0)
50 (5)
50 (5)
0 (0)

0 (0)
50 (3)
33 (2)
17 (1)

4 (1)
75 (18)
21 (5)
0 (0)

0 (0)
81 (13)
19 (3)

8 (3)
92 (33)
0 (0)

0 (0)
57 (4)
43 (3)

0 (0)
100 (13)
0 (0)

0 (0)
57 (4)
43 (3)

12 (3)
88 (23)
0 (0)

0 (0)
100 (9)
0 (0)

0 (0)
100 (10)
0 (0)

0 (0)
83 (5)
17 (1)

4 (1)
96 (23)
0 (0)

6 (1)
6 (1)
82 (13)
6 (1)

16 (7)
37 (15)
37 (15)
10 (4)

0 (0)
0 (0)
86 (6)
14 (1)

0 (0)
29 (4)
57 (8)
14 (2)

14 (1)
14 (1)
58 (4)
14 (1)

20 (6)
47 (14)
27 (8)
6 (2)

0 (0)
0 (0)
100 (9)
0 (0)

9 (1)
9 (1)
64 (7)
8 (2)

17 (1)
17 (1)
49 (3)
17 (1)

14 (4)
50 (14)
32 (9)
4 (1)

6 (1)
88 (14)
6 (1)

15 (6)
75 (30)
10 (4)

0 (0)
86 (6)
14 (1)

0 (0)
88 (14)
12 (2)

14 (1)
72 (5)
14 (1)

21 (6)
72 (20)
7 (2)

0 (0)
100 (9)
0 (0)

0 (0)
83 (10)
17 (2)

17 (1)
66 (4)
17 (1)

15 (4)
81 (21)
4 (1)

13 (2)
74 (12)
13 (2)

41 (15)
59 (22)
0 (0)

0 (0)
71 (5)
29 (2)

46 (6)
54 (7)
0 (0)

14 (1)
57 (4)
29 (2)

43 (12)
57 (16)
0 (0)

11 (1)
89 (8)
0 (0)

22 (2)
78 (7)
0 (0)

17 (1)
66 (4)
17 (1)

50 (13)
50 (13)
0 (0)

0 (0)
68 (11)
13 (2)
19 (3)

5 (2)
73 (27)
19 (7)
3 (1)

0 (0)
43 (3)
14 (1)
43 (3)

8 (1)
84 (11)
8 (1)
0 (0)

0 (0)
57 (4)
0 (0)
43 (3)

7 (2)
71 (20)
18 (5)
4 (1)

0 (0)
78 (7)
22 (2)
0 (0)

0 (0)
78 (7)
22 (2)
0 (0)

0 (0)
83 (5)
0 (0)
17 (1)

4 (1)
77 (20)
15 (4)
4 (1)

Older adults (> 50 y)
PROWITH
PRO-BET
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Appendix B Table 6 Continued. Qualitative assessment on the magnitude of effect of consuming a protein supplement with versus between meals on body
composition changes in resistance training adults 1,2,3
Lean mass:Fat mass
ratio
Increased
100 (16)
84 (31)
100 (7)
77 (10)
100 (7)
82 (23)
100 (9)
89 (8)
100 (6)
88 (23)
Decreased
0 (0)
16 (6)
0 (0)
23 (3)
0 (0)
18 (5)
0 (0)
11 (1)
0 (0)
12 (3)
1
Values are the percent of groups (number of groups); PRO-WITH, groups ingesting protein supplements with meals; PRO-BET, groups ingesting protein
supplements between meals.
2
Each body composition analysis is composed of a different sample size
3
The type of protein-rich supplement varied across groups; some studies have contributed more than one intervention group
4
Analysis only includes protein doses from supplements that are ≥ 0.24 and 0.40 g/kg/body mass in younger and older adults, respectively. This was calculated
by dividing the protein dose by the group mean body mass.
5
Analysis only includes intervention that supplemented between 10 and 75 g of protein/d. This was selected based on the lower and upper quantities that were
available for comparison in both groups.
6
Analysis only includes interventions that reported total protein intakes between 0.9-1.6 g protein/kg/d.
7
Analysis only includes interventions that supplemented between 10 and 75 g of protein/d and reported total protein intakes between 0.9-1.6 g protein/kg/d.
8
Analysis only includes interventions that did not include creatine supplementation; only the PRO-BET category contained groups that supplemented with
creatine, therefore, the results in PRO-WITH are unchanged from the original analysis.
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Appendix B Table 6 continued. Qualitative assessment on the magnitude of effect of consuming a protein supplement with versus between meals on body
composition changes in resistance training adults 1,2,3

Amount of change
Body mass (kg)
< 10 to ≥ 5 kg gain
< 5 to ≥ 0 kg gain
> 0 to < 5 kg loss
≥ 5 to < 10 kg loss
Body mass (%)
< 10 to ≥ 5 % gain
<±5%
≥ 5 to < 10 % loss
Lean mass (kg)
≥ 3 kg gain
< 3 to ≥ 1.5 kg gain
< 1.5 to ≥ 0 kg gain
> 0 to < 1.5 kg loss

All interventions
PROPROWITH
BET

Range matched for
total protein
supplemented5
PROPROWITH
BET

Range matched for
total protein intake6
PROPROWITH
BET

Range matched for
total protein
supplemented and
total protein intake7
PROPROWITH
BET

No creatine
supplementation8
PROPROWITH
BET

0 (0)
56 (9)
25 (4)
19 (3)

8 (3)
64 (23)
28 (10)
0 (0)

0 (0)
60 (9)
27 (4)
13 (2)

10 (3)
55 (16)
35 (10)
0 (0)

0 (0)
67 (6)
22 (2)
11 (1)

7 (1)
40 (6)
53 (8)
0 (0)

0 (0)
67 (6)
22 (2)
11 (1)

9 (1)
36 (4)
55 (6)
0 (0)

0 (0)
56 (9)
25 (4)
19 (3)

11 (3)
57 (16)
32 (9)
0 (0)

0 (0)
81 (13)
19 (3)

8 (3)
92 (33)
0 (0)

0 (0)
87 (13)
13 (2)

10 (3)
90 (26)
0 (0)

0 (0)
89 (8)
11 (1)

7 (1)
93 (14)
0 (0)

0 (0)
89 (8)
11 (1)

9 (1)
91 (10)
0 (0)

0 (0)
81 (13)
19 (3)

7 (2)
93 (26)
0 (0)

6 (1)
6 (1)
82 (13)
6 (1)

16 (7)
37 (15)
37 (15)
10 (4)

7 (1)
7 (1)
79 (12)
7 (1)

16 (5)
28 (9)
44 (14)
12 (4)

11 (1)
11 (1)
78 (7)
0 (0)

12 (2)
19 (3)
50 (8)
19 (3)

11 (1)
11 (1)
78 (7)
0 (0)

17 (2)
17 (2)
49 (6)
17 (2)

6 (1)
6 (1)
82 (13)
6 (1)

12 (4)
30 (10)
46 (15)
12 (4)
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Appendix B Table 6 continued. Qualitative assessment on the magnitude of effect of consuming a protein supplement with versus between meals on body
composition changes in resistance training adults 1,2,3
Lean mass (%)
< 10 to ≥ 5 % gain
6 (1)
15 (6)
7 (1)
12 (4)
11 (1)
7 (1)
11 (1)
9 (1)
6 (1)
12 (4)
< 5 to ≥ 0 % gain
88 (14)
75 (30)
86 (13)
76 (25)
89 (8)
73 (11)
89 (8)
73 (8)
88 (14)
88 (29)
> 0 to < 5 % loss
6 (1)
10 (4)
7 (1)
12 (4)
0 (0
20 (3)
0 (0
18 (2)
6 (1)
0 (0)
Fat mass (kg)
< 5 to ≥ 0 kg gain
13 (2)
41 (15)
13 (2)
33 (10)
22 (2)
14 (2)
22 (2)
20 (2)
13 (2)
33 (10)
> 0 to < 5 kg loss
74 (12)
59 (22)
80 (12)
67 (20)
78 (7)
86 (12)
78 (7)
80 (8)
74 (12)
67 (20)
≥ 5 to ≤ 10 kg loss
13 (2)
0 (0)
7 (1)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
13 (2)
0 (0)
Fat mass (%)
< 10 to ≥ 5 % gain
0 (0)
5 (2)
0 (0)
7 (2)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
7 (2)
<±5%
68 (11)
73 (27)
74 (11)
70 (21)
89 (8)
79 (11)
89 (8)
80 (8)
68 (11)
66 (19)
≥ 5 to < 10 % loss
13 (2)
19 (7)
13 (2)
20 (6)
0 (0)
21 (3)
0 (0)
20 (2)
13 (2)
24 (7)
≥ 10 % loss
19 (3)
3 (1)
13 (2)
3 (1)
11 (1)
0 (0)
11 (1)
0 (0)
19 (3)
3 (1)
Lean mass:Fat
mass ratio
Increased
100 (16)
84 (31)
100 (15)
80 (24)
100 (9)
86 (12)
100 (9)
90 (9)
100 (16)
87 (25)
Decreased
0 (0)
16 (6)
0 (0)
20 (6)
0 (0)
14 (2)
0 (0)
10 (1)
0 (0)
13 (5)
1
Values are the percent of groups (number of groups); PRO-WITH, groups ingesting protein supplements with meals; PRO-BET, groups
ingesting protein supplements between meals.
2
Each body composition analysis is composed of a different sample size
3
The type of protein-rich supplement varied across groups; some studies have contributed more than one intervention group
4
Analysis only includes protein doses from supplements that are ≥ 0.24 and 0.40 g/kg/body mass in younger and older adults, respectively. This
was calculated by dividing the protein dose by the group mean body mass.
5
Analysis only includes intervention that supplemented between 10 and 75 g of protein/d. This was selected based on the lower and upper
quantities that were available for comparison in both groups.
6
Analysis only includes interventions that reported total protein intakes between 0.9-1.6 g protein/kg/d.
7
Analysis only includes interventions that supplemented between 10 and 75 g of protein/d and reported total protein intakes between 0.9-1.6 g
protein/kg/d.
8
Analysis only includes interventions that did not include creatine supplementation; only the PRO-BET category contained groups that
supplemented with creatine, therefore, the results in PRO-WITH are unchanged from the original analysis.
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